Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References FTP Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer ACP Haplotyper Genome Scanner
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:cephalosporin
go back to main search page
Accession:CHEBI:23066 term browser browse the term
Definition:A class of beta-lactam antibiotics differing from the penicillins in having a 6-membered, rather than a 5-membered, side ring. Although cephalosporins are among the most commonly used antibiotics in the treatment of routine infections, and their use is increasing over time, they can cause a range of hypersensitivity reactions, from mild, delayed-onset cutaneous reactions to life-threatening anaphylaxis in patients with immunoglobulin E (IgE)-mediated allergy.
Synonyms:related_synonym: Formula=C7H5NO3SR2;   SMILES=[H][C@]12SCC([*])=C(N1C(=O)[C@H]2[*])C(O)=O;   cephalosphorin;   cephalosphorins;   cephalosporins
 alt_id: CHEBI:3538
 xref: KEGG:C00875;   PMID:10069359;   PMID:11936371;   PMID:12833570;   PMID:24269048;   PMID:3320614;   PMID:6762896;   PMID:8426246;   Wikipedia:Cephalosporin

show annotations for term's descendants           Sort by:
 
7beta-aminocephalosporanic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ampd3 adenosine monophosphate deaminase 3 increases expression ISO 7-aminocephalosporanic acid results in increased expression of AMPD3 mRNA CTD PMID:24211530 NCBI chr 1:175,585,301...175,630,479
Ensembl chr 1:175,586,097...175,630,467 		JBrowse link
G Fth1 ferritin heavy chain 1 increases expression ISO 7-aminocephalosporanic acid results in increased expression of FTH1 mRNA CTD PMID:24211530 NCBI chr 1:226,030,940...226,033,228
Ensembl chr 1:226,030,938...226,033,228 		JBrowse link
G Ftl1 ferritin light chain 1 increases expression ISO 7-aminocephalosporanic acid results in increased expression of FTL mRNA CTD PMID:24211530 NCBI chr 1:101,448,190...101,450,034
Ensembl chr 1:101,448,346...101,449,829 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit increases expression ISO 7-aminocephalosporanic acid results in increased expression of GCLM mRNA CTD PMID:24211530 NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression ISO 7-aminocephalosporanic acid results in increased expression of HMOX1 mRNA CTD PMID:24211530 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor increases expression ISO 7-aminocephalosporanic acid results in increased expression of MYC mRNA CTD PMID:24211530 NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression ISO 7-aminocephalosporanic acid results in increased expression of NQO1 mRNA CTD PMID:24211530 NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180 		JBrowse link
G Sel1l3 SEL1L family member 3 increases expression ISO 7-aminocephalosporanic acid results in increased expression of SEL1L3 mRNA CTD PMID:24211530 NCBI chr14:60,122,968...60,229,565
Ensembl chr14:60,123,169...60,229,734 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression ISO 7-aminocephalosporanic acid results in increased expression of SLC7A11 mRNA CTD PMID:24211530 NCBI chr 2:139,453,774...139,528,479
Ensembl chr 2:139,453,774...139,528,162 		JBrowse link
G Sqstm1 sequestosome 1 increases expression ISO 7-aminocephalosporanic acid results in increased expression of SQSTM1 mRNA CTD PMID:24211530 NCBI chr10:35,704,728...35,716,316
Ensembl chr10:35,704,730...35,716,294 		JBrowse link
G Syne2 spectrin repeat containing nuclear envelope protein 2 decreases expression ISO 7-aminocephalosporanic acid results in decreased expression of SYNE2 mRNA CTD PMID:24211530 NCBI chr 6:98,884,269...99,153,551 JBrowse link
G Tnnt2 troponin T2, cardiac type decreases expression ISO 7-aminocephalosporanic acid results in decreased expression of TNNT2 mRNA CTD PMID:24211530 NCBI chr13:52,662,974...52,680,992
Ensembl chr13:52,662,996...52,680,990 		JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression ISO 7-aminocephalosporanic acid results in increased expression of TXNRD1 mRNA CTD PMID:24211530 NCBI chr 7:26,946,124...26,984,400
Ensembl chr 7:26,946,125...26,984,400 		JBrowse link
cefaclor term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions
decreases activity		 ISO Cefaclor inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
Cefaclor results in decreased activity of ABCB11 protein		 CTD PMID:24014644 NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946 		JBrowse link
G Cyp3a62 cytochrome P450, family 3, subfamily a, polypeptide 62 increases expression ISO Cefaclor results in increased expression of CYP3A4 mRNA; Cefaclor results in increased expression of CYP3A4 protein CTD PMID:18505790 NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397 		JBrowse link
G Slc22a6 solute carrier family 22 member 6 multiple interactions ISO Cefaclor inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] CTD PMID:16098483 NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 increases uptake
multiple interactions		 ISO SLC22A8 protein results in increased uptake of Cefaclor
Cefaclor inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]		 CTD PMID:16098483 NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482 		JBrowse link
cefadroxil term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp3a62 cytochrome P450, family 3, subfamily a, polypeptide 62 increases expression ISO Cefadroxil results in increased expression of CYP3A4 mRNA; Cefadroxil results in increased expression of CYP3A4 protein CTD PMID:18505790 NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397 		JBrowse link
cefaloridine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aadac arylacetamide deacetylase increases expression EXP Cephaloridine results in increased expression of AADAC mRNA CTD PMID:18500788 NCBI chr 2:150,146,234...150,157,480
Ensembl chr 2:150,146,234...150,157,480 		JBrowse link
G Aass aminoadipate-semialdehyde synthase decreases expression EXP Cephaloridine results in decreased expression of AASS mRNA CTD PMID:18500788 NCBI chr 4:50,152,005...50,208,935
Ensembl chr 4:50,152,452...50,200,328 		JBrowse link
G Abcb1b ATP-binding cassette, subfamily B (MDR/TAP), member 1B increases expression EXP Cephaloridine results in increased expression of ABCB1B mRNA CTD PMID:18500788 NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 increases expression EXP Cephaloridine results in increased expression of ABCC2 mRNA CTD PMID:18500788 NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252 		JBrowse link
G Acmsd aminocarboxymuconate semialdehyde decarboxylase decreases expression EXP Cephaloridine results in decreased expression of ACMSD mRNA CTD PMID:18500788 NCBI chr13:44,424,689...44,468,734
Ensembl chr13:44,424,689...44,468,734 		JBrowse link
G Acot9 acyl-CoA thioesterase 9 increases expression EXP Cephaloridine results in increased expression of ACOT9 mRNA CTD PMID:18500788 NCBI chr  X:43,543,069...43,592,200
Ensembl chr  X:43,543,070...43,592,200 		JBrowse link
G Acsm5 acyl-CoA synthetase medium-chain family member 5 decreases expression EXP Cephaloridine results in decreased expression of ACSM5 mRNA CTD PMID:18500788 NCBI chr 1:189,240,955...189,270,422
Ensembl chr 1:189,233,141...189,272,172 		JBrowse link
G Adam8 ADAM metallopeptidase domain 8 decreases expression EXP Cephaloridine results in decreased expression of ADAM8 mRNA CTD PMID:18500788 NCBI chr 1:212,317,510...212,332,895
Ensembl chr 1:212,317,848...212,330,349 		JBrowse link
G Adgre1 adhesion G protein-coupled receptor E1 increases expression EXP Cephaloridine results in increased expression of ADGRE1 mRNA CTD PMID:18500788 NCBI chr 9:9,431,888...9,585,883
Ensembl chr 9:9,431,860...9,585,865 		JBrowse link
G Adora2a adenosine A2a receptor increases expression EXP Cephaloridine results in increased expression of ADORA2A mRNA CTD PMID:18500788 NCBI chr20:14,265,251...14,282,873
Ensembl chr20:14,265,252...14,282,873 		JBrowse link
G Adra1d adrenoceptor alpha 1D increases expression EXP Cephaloridine results in increased expression of ADRA1D mRNA CTD PMID:18500788 NCBI chr 3:124,129,558...124,145,566
Ensembl chr 3:124,129,558...124,145,566 		JBrowse link
G Aftph aftiphilin decreases expression EXP Cephaloridine results in decreased expression of AFTPH mRNA CTD PMID:18500788 NCBI chr14:104,921,633...104,975,763
Ensembl chr14:104,922,282...104,960,141 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B increases expression EXP Cephaloridine results in increased expression of AKR1B1 mRNA CTD PMID:18172885 NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956 		JBrowse link
G Akr1b8 aldo-keto reductase family 1, member B8 increases expression EXP Cephaloridine results in increased expression of AKR1B8 mRNA CTD PMID:18500788 NCBI chr 4:61,772,064...61,784,637
Ensembl chr 4:61,771,970...61,828,657 		JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 increases expression EXP Cephaloridine results in increased expression of AKR1D1 mRNA CTD PMID:18172885 NCBI chr 4:65,110,706...65,143,930
Ensembl chr 4:65,110,746...65,143,941 		JBrowse link
G Alas1 5'-aminolevulinate synthase 1 increases expression EXP Cephaloridine results in increased expression of ALAS1 mRNA CTD PMID:18500788 NCBI chr 8:114,927,704...114,941,038
Ensembl chr 8:114,927,722...114,940,177 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression EXP Cephaloridine results in increased expression of ALDH3A1 mRNA CTD PMID:18500788 NCBI chr10:47,490,168...47,499,855
Ensembl chr10:47,490,153...47,499,876 		JBrowse link
G Aldh3b1 aldehyde dehydrogenase 3 family, member B1 increases expression EXP Cephaloridine results in increased expression of ALDH3B1 mRNA CTD PMID:18500788 NCBI chr 1:219,145,457...219,181,536
Ensembl chr 1:219,145,459...219,186,860 		JBrowse link
G Aldoa aldolase, fructose-bisphosphate A affects expression EXP Cephaloridine affects the expression of ALDOA mRNA CTD PMID:18172885 NCBI chr 1:198,228,387...198,233,988
Ensembl chr 1:198,228,387...198,233,588 		JBrowse link
G Amer2 APC membrane recruitment protein 2 decreases expression EXP Cephaloridine results in decreased expression of AMER2 mRNA CTD PMID:18500788 NCBI chr15:40,663,183...40,667,705
Ensembl chr15:40,665,041...40,667,173 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 increases expression EXP Cephaloridine results in increased expression of AMIGO2 mRNA CTD PMID:18500788 NCBI chr 7:138,704,124...138,707,221
Ensembl chr 7:138,704,126...138,707,221 		JBrowse link
G Ampd1 adenosine monophosphate deaminase 1 increases expression EXP Cephaloridine results in increased expression of AMPD1 mRNA CTD PMID:18500788 NCBI chr 2:205,568,934...205,589,961
Ensembl chr 2:205,568,935...205,590,021 		JBrowse link
G Ampd3 adenosine monophosphate deaminase 3 increases expression EXP Cephaloridine results in increased expression of AMPD3 mRNA CTD PMID:18500788 NCBI chr 1:175,585,301...175,630,479
Ensembl chr 1:175,586,097...175,630,467 		JBrowse link
G Angptl4 angiopoietin-like 4 increases expression EXP Cephaloridine results in increased expression of ANGPTL4 mRNA CTD PMID:18500788 NCBI chr 7:18,627,814...18,634,043
Ensembl chr 7:18,627,808...18,634,079 		JBrowse link
G Anln anillin, actin binding protein decreases expression EXP Cephaloridine results in decreased expression of ANLN mRNA CTD PMID:18500788 NCBI chr 8:23,336,455...23,397,122
Ensembl chr 8:23,337,621...23,390,773 		JBrowse link
G Anxa13 annexin A13 decreases expression EXP Cephaloridine results in decreased expression of ANXA13 mRNA CTD PMID:18500788 NCBI chr 7:98,217,642...98,270,442
Ensembl chr 7:98,217,642...98,270,110 		JBrowse link
G Anxa7 annexin A7 increases expression EXP Cephaloridine results in increased expression of ANXA7 mRNA CTD PMID:18500788 NCBI chr15:4,254,470...4,281,296
Ensembl chr15:4,254,499...4,281,287 		JBrowse link
G Apcs amyloid P component, serum decreases expression EXP Cephaloridine results in decreased expression of APCS mRNA CTD PMID:18500788 NCBI chr13:91,426,621...91,427,417
Ensembl chr13:91,426,479...91,427,575 		JBrowse link
G Apoa4 apolipoprotein A4 increases expression EXP Cephaloridine results in increased expression of APOA4 mRNA CTD PMID:18500788 NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376 		JBrowse link
G Apob apolipoprotein B increases expression EXP Cephaloridine results in increased expression of APOB mRNA CTD PMID:18500788 NCBI chr 6:33,176,826...33,216,381
Ensembl chr 6:33,176,778...33,224,997 		JBrowse link
G Apoc2 apolipoprotein C2 increases expression EXP Cephaloridine results in increased expression of APOC2 mRNA CTD PMID:18500788 NCBI chr 1:80,589,023...80,593,991
Ensembl chr 1:80,589,023...80,594,136 		JBrowse link
G Apold1 apolipoprotein L domain containing 1 decreases expression EXP Cephaloridine results in decreased expression of APOLD1 mRNA CTD PMID:18500788 NCBI chr 4:168,752,142...168,755,024
Ensembl chr 4:168,752,133...168,755,023 		JBrowse link
G Arfgef3 ARFGEF family member 3 decreases expression EXP Cephaloridine results in decreased expression of ARFGEF3 mRNA CTD PMID:18500788 NCBI chr 1:13,837,861...13,918,277
Ensembl chr 1:13,838,707...13,915,594 		JBrowse link
G Arhgap35 Rho GTPase activating protein 35 decreases expression EXP Cephaloridine results in decreased expression of ARHGAP35 mRNA CTD PMID:18500788 NCBI chr 1:78,456,409...78,573,374
Ensembl chr 1:78,456,409...78,573,374 		JBrowse link
G Arid5a AT-rich interaction domain 5A increases expression EXP Cephaloridine results in increased expression of ARID5A mRNA CTD PMID:18500788 NCBI chr 9:42,871,907...42,886,725
Ensembl chr 9:42,871,950...42,884,855 		JBrowse link
G Asf1b anti-silencing function 1B histone chaperone increases expression EXP Cephaloridine results in increased expression of ASF1B mRNA CTD PMID:18500788 NCBI chr19:25,077,918...25,092,491
Ensembl chr19:25,077,918...25,092,491 		JBrowse link
G Ash1l ASH1 like histone lysine methyltransferase decreases expression EXP Cephaloridine results in decreased expression of ASH1L mRNA CTD PMID:18500788 NCBI chr 2:188,252,592...188,389,251
Ensembl chr 2:188,253,220...188,389,250 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression EXP Cephaloridine results in increased expression of ASNS mRNA CTD PMID:18500788 NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163 		JBrowse link
G Atad1 ATPase family, AAA domain containing 1 increases expression EXP Cephaloridine results in increased expression of ATAD1 mRNA CTD PMID:18500788 NCBI chr 1:251,234,702...251,386,996
Ensembl chr 1:251,235,508...251,387,002 		JBrowse link
G Atad2 ATPase family, AAA domain containing 2 increases expression EXP Cephaloridine results in increased expression of ATAD2 mRNA CTD PMID:18500788 NCBI chr 7:97,984,754...98,027,379
Ensembl chr 7:97,984,862...98,026,052 		JBrowse link
G Atf3 activating transcription factor 3 decreases expression EXP Cephaloridine results in decreased expression of ATF3 mRNA CTD PMID:18500788 NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632 		JBrowse link
G Atl1 atlastin GTPase 1 increases expression EXP Cephaloridine results in increased expression of ATL1 mRNA CTD PMID:18500788 NCBI chr 6:92,229,764...92,370,428
Ensembl chr 6:92,229,686...92,370,421 		JBrowse link
G Atp11c ATPase phospholipid transporting 11C decreases expression EXP Cephaloridine results in decreased expression of ATP11C mRNA CTD PMID:18500788 NCBI chr  X:143,340,712...143,525,588
Ensembl chr  X:143,346,252...143,453,612 		JBrowse link
G Atp12a ATPase H+/K+ transporting non-gastric alpha2 subunit increases expression EXP Cephaloridine results in increased expression of ATP12A mRNA CTD PMID:18500788 NCBI chr15:36,561,306...36,590,171
Ensembl chr15:36,565,495...36,590,171 		JBrowse link
G Aurkb aurora kinase B decreases expression EXP Cephaloridine results in decreased expression of AURKB mRNA CTD PMID:18500788 NCBI chr10:55,625,860...55,632,399
Ensembl chr10:55,626,741...55,634,991 		JBrowse link
G B3galt2 Beta-1,3-galactosyltransferase 2 decreases expression EXP Cephaloridine results in decreased expression of B3GALT2 mRNA CTD PMID:18500788 NCBI chr13:60,435,946...60,444,957
Ensembl chr13:60,435,946...60,444,957 		JBrowse link
G B3gnt7 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 decreases expression EXP Cephaloridine results in decreased expression of B3GNT7 mRNA CTD PMID:18500788 NCBI chr 9:93,326,283...93,330,234
Ensembl chr 9:93,326,283...93,330,233 		JBrowse link
G Bag3 BAG cochaperone 3 increases expression EXP Cephaloridine results in increased expression of BAG3 mRNA CTD PMID:18500788 NCBI chr 1:199,941,258...199,965,191
Ensembl chr 1:199,941,161...199,965,191 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 increases expression EXP Cephaloridine results in increased expression of BAK1 mRNA CTD PMID:18500788 NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260 		JBrowse link
G Bard1 BRCA1 associated RING domain 1 increases expression EXP Cephaloridine results in increased expression of BARD1 mRNA CTD PMID:18500788 NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031 		JBrowse link
G Batf basic leucine zipper ATF-like transcription factor increases expression EXP Cephaloridine results in increased expression of BATF mRNA CTD PMID:18500788 NCBI chr 6:109,562,415...109,584,541
Ensembl chr 6:109,562,587...109,584,545 		JBrowse link
G Bcl2l1 Bcl2-like 1 affects expression EXP Cephaloridine affects the expression of BCL2L1 mRNA CTD PMID:18172885 NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810 		JBrowse link
G Bex1 brain expressed, X-linked 1 increases expression EXP Cephaloridine results in increased expression of BEX1 mRNA CTD PMID:18500788 NCBI chr  X:106,761,388...106,771,656 JBrowse link
G Bex4 brain expressed, X-linked 4 increases expression EXP Cephaloridine results in increased expression of BEX4 mRNA CTD PMID:18500788
G Bhlhe41 basic helix-loop-helix family, member e41 increases expression EXP Cephaloridine results in increased expression of BHLHE41 mRNA CTD PMID:18500788 NCBI chr 4:180,230,742...180,235,138
Ensembl chr 4:180,232,382...180,234,804 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 increases expression EXP Cephaloridine results in increased expression of BIRC3 mRNA CTD PMID:18500788 NCBI chr 8:6,048,590...6,076,828
Ensembl chr 8:6,048,969...6,076,598 		JBrowse link
G Blvrb biliverdin reductase B increases expression EXP Cephaloridine results in increased expression of BLVRB mRNA CTD PMID:18500788 NCBI chr 1:84,256,063...84,273,726
Ensembl chr 1:84,256,159...84,274,075 		JBrowse link
G Bpi bactericidal/permeability-increasing protein increases expression EXP Cephaloridine results in increased expression of BPI mRNA CTD PMID:18500788 NCBI chr 3:154,741,627...154,768,584
Ensembl chr 3:154,741,631...154,768,640 		JBrowse link
G Brip1 BRCA1 interacting protein C-terminal helicase 1 increases expression EXP Cephaloridine results in increased expression of BRIP1 mRNA CTD PMID:18500788 NCBI chr10:73,507,009...73,632,742
Ensembl chr10:73,507,100...73,629,581 		JBrowse link
G Bsnd barttin CLCNK type accessory subunit beta increases expression EXP Cephaloridine results in increased expression of BSND mRNA CTD PMID:18500788 NCBI chr 5:126,071,849...126,080,647
Ensembl chr 5:126,071,846...126,080,698 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 decreases expression EXP Cephaloridine results in decreased expression of BTG2 mRNA CTD PMID:18500788 NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982 		JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B decreases expression EXP Cephaloridine results in decreased expression of BUB1B mRNA CTD PMID:18500788 NCBI chr 3:110,367,949...110,420,471
Ensembl chr 3:110,367,939...110,420,458 		JBrowse link
G C1qtnf1 C1q and TNF related 1 increases expression EXP Cephaloridine results in increased expression of C1QTNF1 mRNA CTD PMID:18500788 NCBI chr10:107,455,845...107,477,160
Ensembl chr10:107,455,845...107,477,162 		JBrowse link
G C5 complement C5 decreases expression EXP Cephaloridine results in decreased expression of C5 mRNA CTD PMID:18500788 NCBI chr 3:14,049,993...14,113,931
NCBI chr 3:14,206,466...14,229,141
Ensembl chr 3:14,049,995...14,229,080 		JBrowse link
G C6 complement C6 increases expression EXP Cephaloridine results in increased expression of C6 mRNA CTD PMID:18500788 NCBI chr 2:54,460,333...54,533,801
Ensembl chr 2:54,466,280...54,533,797 		JBrowse link
G Cacna1h calcium voltage-gated channel subunit alpha1 H increases expression EXP Cephaloridine results in increased expression of CACNA1H mRNA CTD PMID:18500788 NCBI chr10:14,730,932...14,789,201
Ensembl chr10:14,730,941...14,788,617 		JBrowse link
G Cacng3 calcium voltage-gated channel auxiliary subunit gamma 3 increases expression EXP Cephaloridine results in increased expression of CACNG3 mRNA CTD PMID:18500788 NCBI chr 1:192,613,766...192,708,371
Ensembl chr 1:192,613,372...192,709,078 		JBrowse link
G Calb1 calbindin 1 increases expression EXP Cephaloridine results in increased expression of CALB1 mRNA CTD PMID:18500788 NCBI chr 5:29,538,380...29,562,774
Ensembl chr 5:29,538,380...29,562,773 		JBrowse link
G Calb2 calbindin 2 decreases expression EXP Cephaloridine results in decreased expression of CALB2 mRNA CTD PMID:18500788 NCBI chr19:41,482,743...41,509,617
Ensembl chr19:41,482,728...41,509,658 		JBrowse link
G Calr calreticulin increases expression EXP Cephaloridine results in increased expression of CALR mRNA CTD PMID:18172885 NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666 		JBrowse link
G Camkv CaM kinase-like vesicle-associated increases expression EXP Cephaloridine results in increased expression of CAMKV mRNA CTD PMID:18500788 NCBI chr 8:116,715,755...116,730,061
Ensembl chr 8:116,715,755...116,730,061 		JBrowse link
G Canx calnexin increases expression EXP Cephaloridine results in increased expression of CANX mRNA CTD PMID:18172885 NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861 		JBrowse link
G Cat catalase affects expression EXP Cephaloridine affects the expression of CAT protein CTD PMID:9933756 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058 		JBrowse link
G Ccdc113 coiled-coil domain containing 113 increases expression EXP Cephaloridine results in increased expression of CCDC113 mRNA CTD PMID:18500788 NCBI chr19:9,912,124...9,932,183
Ensembl chr19:9,912,183...9,931,930 		JBrowse link
G Ccl17 C-C motif chemokine ligand 17 increases expression EXP Cephaloridine results in increased expression of CCL17 mRNA CTD PMID:18500788 NCBI chr19:10,619,220...10,620,671
Ensembl chr19:10,619,220...10,620,671 		JBrowse link
G Ccl19 C-C motif chemokine ligand 19 increases expression EXP Cephaloridine results in increased expression of CCL19 mRNA CTD PMID:18500788 NCBI chr 5:58,181,025...58,182,969
Ensembl chr 5:58,181,026...58,183,017 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 increases expression EXP Cephaloridine results in increased expression of CCL20 mRNA CTD PMID:18500788 NCBI chr 9:88,918,359...88,921,017
Ensembl chr 9:88,918,433...88,921,001 		JBrowse link
G Ccl28 C-C motif chemokine ligand 28 increases expression EXP Cephaloridine results in increased expression of CCL28 mRNA CTD PMID:18500788 NCBI chr 2:52,379,341...52,403,979
Ensembl chr 2:52,379,341...52,404,246 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 decreases expression EXP Cephaloridine results in decreased expression of CCL3 mRNA CTD PMID:18500788 NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 decreases expression EXP Cephaloridine results in decreased expression of CCL4 mRNA CTD PMID:18500788 NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355 		JBrowse link
G Ccn2 cellular communication network factor 2 decreases expression EXP Cephaloridine results in decreased expression of CCN2 mRNA CTD PMID:18500788 NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773 		JBrowse link
G Ccna2 cyclin A2 decreases expression EXP Cephaloridine results in decreased expression of CCNA2 mRNA CTD PMID:18500788 NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214 		JBrowse link
G Ccnb1 cyclin B1 decreases expression EXP Cephaloridine results in decreased expression of CCNB1 mRNA CTD PMID:18500788 NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221 		JBrowse link
G Ccnb2 cyclin B2 decreases expression EXP Cephaloridine results in decreased expression of CCNB2 mRNA CTD PMID:18500788 NCBI chr 8:76,847,972...76,861,165 JBrowse link
G Ccne1 cyclin E1 increases expression EXP Cephaloridine results in increased expression of CCNE1 mRNA CTD PMID:18500788 NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980 		JBrowse link
G Ccne2 cyclin E2 increases expression EXP Cephaloridine results in increased expression of CCNE2 mRNA CTD PMID:18500788 NCBI chr 5:24,434,077...24,446,406
Ensembl chr 5:24,434,872...24,446,406 		JBrowse link
G Cd52 CD52 molecule decreases expression EXP Cephaloridine results in decreased expression of CD52 mRNA CTD PMID:18500788 NCBI chr 5:152,322,910...152,324,469
Ensembl chr 5:152,322,916...152,324,469 		JBrowse link
G Cd72 Cd72 molecule increases expression EXP Cephaloridine results in increased expression of CD72 mRNA CTD PMID:18500788 NCBI chr 5:58,943,021...58,950,373
Ensembl chr 5:58,943,027...58,950,373 		JBrowse link
G Cd86 CD86 molecule increases expression EXP Cephaloridine results in increased expression of CD86 mRNA CTD PMID:18500788 NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795 		JBrowse link
G Cdc42 cell division cycle 42 decreases expression EXP Cephaloridine results in decreased expression of CDC42 mRNA CTD PMID:18172885 NCBI chr 5:155,690,267...155,728,385
Ensembl chr 5:155,691,390...155,728,300 		JBrowse link
G Cdc45 cell division cycle 45 increases expression EXP Cephaloridine results in increased expression of CDC45 mRNA CTD PMID:18500788 NCBI chr11:86,328,785...86,354,099
Ensembl chr11:86,329,012...86,358,453 		JBrowse link
G Cdc6 cell division cycle 6 increases expression EXP Cephaloridine results in increased expression of CDC6 mRNA CTD PMID:18500788 NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402 		JBrowse link
G Cdca2 cell division cycle associated 2 decreases expression EXP Cephaloridine results in decreased expression of CDCA2 mRNA CTD PMID:18500788 NCBI chr15:44,365,396...44,411,601
Ensembl chr15:44,365,405...44,411,004 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 decreases expression EXP Cephaloridine results in decreased expression of CDK1 mRNA CTD PMID:18500788 NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549 		JBrowse link
G Cdkl1 cyclin dependent kinase like 1 decreases expression EXP Cephaloridine results in decreased expression of CDKL1 mRNA CTD PMID:18500788 NCBI chr 6:92,076,247...92,123,108
Ensembl chr 6:92,077,416...92,121,351 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A decreases expression EXP Cephaloridine results in decreased expression of CDKN1A mRNA CTD PMID:18500788 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B decreases expression EXP Cephaloridine results in decreased expression of CDKN1B mRNA CTD PMID:18500788 NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964 		JBrowse link
G Cdt1 chromatin licensing and DNA replication factor 1 increases expression EXP Cephaloridine results in increased expression of CDT1 mRNA CTD PMID:18500788 NCBI chr19:55,381,565...55,386,511
Ensembl chr19:55,381,565...55,386,511 		JBrowse link
G Ceacam16 CEA cell adhesion molecule 16, tectorial membrane component increases expression EXP Cephaloridine results in increased expression of CEACAM16 mRNA CTD PMID:18500788 NCBI chr 1:80,773,819...80,783,898
Ensembl chr 1:80,773,819...80,783,898 		JBrowse link
G Cenpk centromere protein K increases expression EXP Cephaloridine results in increased expression of CENPK mRNA CTD PMID:18500788 NCBI chr 2:34,312,766...34,373,945
Ensembl chr 2:34,312,766...34,335,776 		JBrowse link
G Cenpq centromere protein Q increases expression EXP Cephaloridine results in increased expression of CENPQ mRNA CTD PMID:18500788 NCBI chr 9:23,352,271...23,368,774 JBrowse link
G Cesl1 carboxylesterase-like 1 decreases expression EXP Cephaloridine results in decreased expression of CESL1 mRNA CTD PMID:18500788 Ensembl chr19:15,081,158...15,335,002 JBrowse link
G Chaf1a chromatin assembly factor 1 subunit A increases expression EXP Cephaloridine results in increased expression of CHAF1A mRNA CTD PMID:18500788 NCBI chr 9:11,000,869...11,027,631
Ensembl chr 9:11,001,129...11,027,506 		JBrowse link
G Chaf1b chromatin assembly factor 1 subunit B increases expression EXP Cephaloridine results in increased expression of CHAF1B mRNA CTD PMID:18500788 NCBI chr11:34,101,248...34,121,371
Ensembl chr11:34,101,197...34,121,378 		JBrowse link
G Chd4 chromodomain helicase DNA binding protein 4 decreases expression EXP Cephaloridine results in decreased expression of CHD4 mRNA CTD PMID:18500788 NCBI chr 4:157,612,531...157,645,660
Ensembl chr 4:157,612,536...157,645,659 		JBrowse link
G Chd6 chromodomain helicase DNA binding protein 6 decreases expression EXP Cephaloridine results in decreased expression of CHD6 mRNA CTD PMID:18500788 NCBI chr 3:156,937,746...157,099,328
Ensembl chr 3:156,937,733...157,099,306 		JBrowse link
G Chek1 checkpoint kinase 1 increases expression EXP Cephaloridine results in increased expression of CHEK1 mRNA CTD PMID:18500788 NCBI chr 8:39,181,162...39,201,588
Ensembl chr 8:39,181,163...39,243,882 		JBrowse link
G Chst7 carbohydrate sulfotransferase 7 decreases expression EXP Cephaloridine results in decreased expression of CHST7 mRNA CTD PMID:18500788 NCBI chr  X:2,623,018...2,657,155
Ensembl chr  X:2,623,024...2,657,155 		JBrowse link
G Chtf18 chromosome transmission fidelity factor 18 increases expression EXP Cephaloridine results in increased expression of CHTF18 mRNA CTD PMID:18500788 NCBI chr10:15,090,762...15,098,825
Ensembl chr10:15,090,316...15,098,791 		JBrowse link
G Cilp cartilage intermediate layer protein decreases expression EXP Cephaloridine results in decreased expression of CILP mRNA CTD PMID:18500788 NCBI chr 8:70,760,922...70,775,891
Ensembl chr 8:70,760,922...70,775,891 		JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 increases expression EXP Cephaloridine results in increased expression of CITED2 mRNA CTD PMID:18172885 NCBI chr 1:12,823,363...12,825,806
Ensembl chr 1:12,823,363...12,825,786 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 decreases expression EXP Cephaloridine results in decreased expression of CKAP2 mRNA CTD PMID:18500788 NCBI chr16:74,752,655...74,779,184
Ensembl chr16:74,752,655...74,779,184 		JBrowse link
G Cldn14 claudin 14 increases expression EXP Cephaloridine results in increased expression of CLDN14 mRNA CTD PMID:18500788 NCBI chr11:34,132,581...34,142,813
Ensembl chr11:34,132,581...34,142,753 		JBrowse link
G Clstn2 calsyntenin 2 decreases expression EXP Cephaloridine results in decreased expression of CLSTN2 mRNA CTD PMID:18500788 NCBI chr 8:105,322,577...106,036,821
Ensembl chr 8:105,323,837...105,462,168 		JBrowse link
G Cmip c-Maf-inducing protein decreases expression EXP Cephaloridine results in decreased expression of CMIP mRNA CTD PMID:18500788 NCBI chr19:49,792,273...50,000,535
Ensembl chr19:49,792,273...50,000,535 		JBrowse link
G Cndp1 carnosine dipeptidase 1 decreases expression EXP Cephaloridine results in decreased expression of CNDP1 mRNA CTD PMID:18500788 NCBI chr18:81,466,717...81,512,841
Ensembl chr18:81,466,716...81,499,051 		JBrowse link
G Col4a4 collagen type IV alpha 4 chain decreases expression EXP Cephaloridine results in decreased expression of COL4A4 mRNA CTD PMID:18500788 NCBI chr 9:88,314,763...88,357,183
Ensembl chr 9:88,232,455...88,357,182 		JBrowse link
G Col7a1 collagen type VII alpha 1 chain increases expression EXP Cephaloridine results in increased expression of COL7A1 mRNA CTD PMID:18500788 NCBI chr 8:117,694,441...117,726,844
Ensembl chr 8:117,694,605...117,726,844 		JBrowse link
G Cpt1b carnitine palmitoyltransferase 1B increases expression EXP Cephaloridine results in increased expression of CPT1B mRNA CTD PMID:18500788 NCBI chr 7:130,395,211...130,404,731
Ensembl chr 7:130,395,194...130,405,347 		JBrowse link
G Crabp1 cellular retinoic acid binding protein 1 increases expression EXP Cephaloridine results in increased expression of CRABP1 mRNA CTD PMID:18500788 NCBI chr 8:59,344,097...59,352,135
Ensembl chr 8:59,344,083...59,352,132 		JBrowse link
G Crebbp CREB binding protein decreases expression EXP Cephaloridine results in decreased expression of CREBBP mRNA CTD PMID:18500788 NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039 		JBrowse link
G Cry1 cryptochrome circadian regulator 1 increases expression EXP Cephaloridine results in increased expression of CRY1 mRNA CTD PMID:18500788 NCBI chr 7:24,534,593...24,634,098
Ensembl chr 7:24,534,615...24,634,097 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 decreases expression EXP Cephaloridine results in decreased expression of CXCL1 mRNA CTD PMID:18500788 NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression EXP Cephaloridine results in increased expression of CXCL10 mRNA CTD PMID:18500788 NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930 		JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 increases expression EXP Cephaloridine results in increased expression of CXCL13 mRNA CTD PMID:18500788 NCBI chr14:15,253,146...15,258,221
Ensembl chr14:15,253,125...15,258,207 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 increases expression EXP Cephaloridine results in increased expression of CXCL14 mRNA CTD PMID:18500788 NCBI chr17:9,109,731...9,117,754
Ensembl chr17:9,109,731...9,117,750 		JBrowse link
G Cxxc4 CXXC finger protein 4 decreases expression EXP Cephaloridine results in decreased expression of CXXC4 mRNA CTD PMID:18500788 NCBI chr 2:239,414,882...239,439,640
Ensembl chr 2:239,415,046...239,439,568 		JBrowse link
G Cyb5a cytochrome b5 type A increases expression EXP Cephaloridine results in increased expression of CYB5A mRNA CTD PMID:18172885 NCBI chr18:81,694,818...81,726,821
Ensembl chr18:81,694,808...81,726,821 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression EXP Cephaloridine results in increased expression of CYP1B1 mRNA CTD PMID:18500788 NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722 		JBrowse link
G Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1 decreases expression EXP Cephaloridine results in decreased expression of CYP24A1 mRNA CTD PMID:18500788 NCBI chr 3:168,097,484...168,111,920
Ensembl chr 3:168,097,485...168,111,920 		JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 decreases expression EXP Cephaloridine results in decreased expression of CYP2C mRNA CTD PMID:18500788 NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434 		JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 increases expression EXP Cephaloridine results in increased expression of CYP7B1 mRNA CTD PMID:18500788 NCBI chr 2:102,701,903...102,871,257
Ensembl chr 2:102,701,903...102,871,257 		JBrowse link
G Dctpp1 dCTP pyrophosphatase 1 increases expression EXP Cephaloridine results in increased expression of DCTPP1 mRNA CTD PMID:18500788 NCBI chr 1:198,703,459...198,706,852
Ensembl chr 1:198,703,461...198,706,852 		JBrowse link
G Ddc dopa decarboxylase decreases expression EXP Cephaloridine results in decreased expression of DDC mRNA CTD PMID:18500788 NCBI chr14:91,905,919...91,996,816
Ensembl chr14:91,905,919...91,996,774 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 decreases expression EXP Cephaloridine results in decreased expression of DDIT4 mRNA CTD PMID:18500788 NCBI chr20:29,509,283...29,511,382
Ensembl chr20:29,509,289...29,511,382 		JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like increases expression EXP Cephaloridine results in increased expression of DDIT4L mRNA CTD PMID:18500788 NCBI chr 2:242,882,219...242,885,088
Ensembl chr 2:242,882,306...242,885,131 		JBrowse link
G Ddx39a DExD-box helicase 39A increases expression EXP Cephaloridine results in increased expression of DDX39A mRNA CTD PMID:18500788 NCBI chr19:24,846,530...24,854,886
Ensembl chr19:24,846,938...24,854,953 		JBrowse link
G Ddx6 DEAD-box helicase 6 decreases expression EXP Cephaloridine results in decreased expression of DDX6 mRNA CTD PMID:18500788 NCBI chr 8:48,924,768...48,961,394
Ensembl chr 8:48,925,604...48,958,026 		JBrowse link
G Decr2 2,4-dienoyl-CoA reductase 2 decreases expression EXP Cephaloridine results in decreased expression of DECR2 mRNA CTD PMID:18500788 NCBI chr10:15,451,850...15,460,227
Ensembl chr10:15,431,638...15,465,413 		JBrowse link
G Dlgap1 DLG associated protein 1 increases expression EXP Cephaloridine results in increased expression of DLGAP1 mRNA CTD PMID:18500788 NCBI chr 9:118,277,046...119,159,807
Ensembl chr 9:118,586,179...119,158,196 		JBrowse link
G Dnah7 dynein, axonemal, heavy chain 7 decreases expression EXP Cephaloridine results in decreased expression of DNAH7 mRNA CTD PMID:18500788 NCBI chr 9:60,070,087...60,330,121
NCBI chr 9:59,564,253...59,595,347
Ensembl chr 9:60,070,739...60,330,125
Ensembl chr 9:60,070,739...60,330,125 		JBrowse link
G Dnah9 dynein, axonemal, heavy chain 9 decreases expression EXP Cephaloridine results in decreased expression of DNAH9 mRNA CTD PMID:18500788 NCBI chr10:52,351,226...52,711,289
Ensembl chr10:52,351,192...52,710,862 		JBrowse link
G Dnase1l3 deoxyribonuclease 1-like 3 increases expression EXP Cephaloridine results in increased expression of DNASE1L3 mRNA CTD PMID:18500788 NCBI chr15:18,710,492...18,736,476
Ensembl chr15:18,710,492...18,736,473 		JBrowse link
G Dnph1 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 increases expression EXP Cephaloridine results in increased expression of DNPH1 mRNA CTD PMID:18500788 NCBI chr 9:16,845,764...16,848,514
Ensembl chr 9:16,845,525...16,848,503 		JBrowse link
G Donson DNA replication fork stabilization factor DONSON increases expression EXP Cephaloridine results in increased expression of DONSON mRNA CTD PMID:18500788 NCBI chr11:31,834,608...31,847,751
Ensembl chr11:31,837,839...31,847,490 		JBrowse link
G Dpf1 double PHD fingers 1 increases expression EXP Cephaloridine results in increased expression of DPF1 mRNA CTD PMID:18500788 NCBI chr 1:87,248,448...87,258,070
Ensembl chr 1:87,248,489...87,258,070 		JBrowse link
G Dscc1 DNA replication and sister chromatid cohesion 1 increases expression EXP Cephaloridine results in increased expression of DSCC1 mRNA CTD PMID:18500788 NCBI chr 7:94,759,076...94,774,787
Ensembl chr 7:94,758,800...94,774,569 		JBrowse link
G Dsg2 desmoglein 2 increases expression EXP Cephaloridine results in increased expression of DSG2 mRNA CTD PMID:18500788 NCBI chr18:15,579,322...15,637,720
Ensembl chr18:15,579,315...15,637,715 		JBrowse link
G Dtx4 deltex E3 ubiquitin ligase 4 increases expression EXP Cephaloridine results in increased expression of DTX4 mRNA CTD PMID:18500788 NCBI chr 1:228,729,842...228,759,783
Ensembl chr 1:228,732,985...228,755,866 		JBrowse link
G Dusp6 dual specificity phosphatase 6 affects expression EXP Cephaloridine affects the expression of DUSP6 mRNA CTD PMID:18172885 NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392 		JBrowse link
G Dusp7 dual specificity phosphatase 7 decreases expression EXP Cephaloridine results in decreased expression of DUSP7 mRNA CTD PMID:18500788 NCBI chr 8:115,069,095...115,076,130
Ensembl chr 8:115,069,095...115,076,130 		JBrowse link
G Dusp9 dual specificity phosphatase 9 increases expression EXP Cephaloridine results in increased expression of DUSP9 mRNA CTD PMID:18500788 NCBI chr  X:157,168,143...157,172,068
Ensembl chr  X:157,168,144...157,172,068 		JBrowse link
G E2f8 E2F transcription factor 8 increases expression EXP Cephaloridine results in increased expression of E2F8 mRNA CTD PMID:18500788 NCBI chr 1:104,185,436...104,203,683
Ensembl chr 1:104,187,100...104,202,591 		JBrowse link
G Edrf1 erythroid differentiation regulatory factor 1 decreases expression EXP Cephaloridine results in decreased expression of EDRF1 mRNA CTD PMID:18500788 NCBI chr 1:205,706,023...205,743,676
Ensembl chr 1:205,706,468...205,743,653 		JBrowse link
G Eef2 eukaryotic translation elongation factor 2 increases expression EXP Cephaloridine results in increased expression of EEF2 mRNA CTD PMID:18172885 NCBI chr 7:11,401,501...11,406,771
Ensembl chr 7:11,401,501...11,406,771 		JBrowse link
G Egr1 early growth response 1 decreases expression EXP Cephaloridine results in decreased expression of EGR1 mRNA CTD PMID:18500788 NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429 		JBrowse link
G Egr2 early growth response 2 decreases expression EXP Cephaloridine results in decreased expression of EGR2 mRNA CTD PMID:18500788 NCBI chr20:22,452,170...22,461,018
Ensembl chr20:22,454,463...22,459,025 		JBrowse link
G Eif4h eukaryotic translation initiation factor 4H increases expression EXP Cephaloridine results in increased expression of EIF4H mRNA CTD PMID:18172885 NCBI chr12:25,093,119...25,109,805
Ensembl chr12:25,093,149...25,109,799 		JBrowse link
G Elf3 E74 like ETS transcription factor 3 increases expression EXP Cephaloridine results in increased expression of ELF3 mRNA CTD PMID:18500788 NCBI chr13:52,083,873...52,088,798
Ensembl chr13:52,083,859...52,088,780 		JBrowse link
G Emb embigin increases expression EXP Cephaloridine results in increased expression of EMB mRNA CTD PMID:18500788 NCBI chr 2:49,682,763...49,733,475
Ensembl chr 2:49,682,754...49,732,253 		JBrowse link
G Eme1 essential meiotic structure-specific endonuclease 1 decreases expression EXP Cephaloridine results in decreased expression of EME1 mRNA CTD PMID:18500788 NCBI chr10:82,366,820...82,375,510
Ensembl chr10:82,367,084...82,374,171 		JBrowse link
G Enc1 ectodermal-neural cortex 1 increases expression EXP Cephaloridine results in increased expression of ENC1 mRNA CTD PMID:18500788 NCBI chr 2:28,049,217...28,061,023
Ensembl chr 2:28,049,217...28,061,029 		JBrowse link
G Eno2 enolase 2 increases expression EXP Cephaloridine results in increased expression of ENO2 mRNA CTD PMID:18500788 NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047 		JBrowse link
G Espl1 extra spindle pole bodies like 1, separase decreases expression EXP Cephaloridine results in decreased expression of ESPL1 mRNA CTD PMID:18500788 NCBI chr 7:143,896,890...143,923,868
Ensembl chr 7:143,897,014...143,923,868 		JBrowse link
G Exo1 exonuclease 1 increases expression EXP Cephaloridine results in increased expression of EXO1 mRNA CTD PMID:18500788 NCBI chr13:93,936,989...93,962,749
Ensembl chr13:93,939,022...93,960,342 		JBrowse link
G F13b coagulation factor XIII B chain decreases expression EXP Cephaloridine results in decreased expression of F13B mRNA CTD PMID:18500788 NCBI chr13:56,598,891...56,623,132
Ensembl chr13:56,598,957...56,623,124 		JBrowse link
G Fam111a FAM111 trypsin like peptidase A decreases expression EXP Cephaloridine results in decreased expression of FAM111A mRNA CTD PMID:18500788 NCBI chr 1:229,003,778...229,019,532
Ensembl chr 1:229,003,961...229,019,527 		JBrowse link
G Fam189a2 family with sequence similarity 189, member A2 increases expression EXP Cephaloridine results in increased expression of FAM189A2 mRNA CTD PMID:18500788 NCBI chr 1:241,822,152...241,876,089
Ensembl chr 1:241,822,626...241,875,864 		JBrowse link
G Fam71a family with sequence similarity 71, member A increases expression EXP Cephaloridine results in increased expression of FAM71A mRNA CTD PMID:18500788 NCBI chr13:109,768,019...109,770,199
Ensembl chr13:109,768,019...109,770,199 		JBrowse link
G Fancd2 FA complementation group D2 increases expression EXP Cephaloridine results in increased expression of FANCD2 mRNA CTD PMID:18500788 NCBI chr 4:145,489,869...145,551,479
Ensembl chr 4:145,489,869...145,551,479 		JBrowse link
G Fbln1 fibulin 1 increases expression EXP Cephaloridine results in increased expression of FBLN1 mRNA CTD PMID:18500788 NCBI chr 7:126,096,793...126,176,468
Ensembl chr 7:126,096,793...126,176,468 		JBrowse link
G Fbp2 fructose-bisphosphatase 2 increases expression EXP Cephaloridine results in increased expression of FBP2 mRNA CTD PMID:18500788 NCBI chr17:372,554...389,918
Ensembl chr17:372,551...389,967 		JBrowse link
G Fbxo5 F-box protein 5 increases expression EXP Cephaloridine results in increased expression of FBXO5 mRNA CTD PMID:18500788 NCBI chr 1:42,461,277...42,467,646
Ensembl chr 1:42,461,291...42,467,586 		JBrowse link
G Fcgr2a Fc fragment of IgG receptor IIa increases expression EXP Cephaloridine results in increased expression of FCGR2A mRNA CTD PMID:18500788 NCBI chr13:91,146,878...91,163,691
Ensembl chr13:91,168,973...91,198,036
Ensembl chr13:91,168,973...91,198,036 		JBrowse link
G Fcgr2b Fc fragment of IgG receptor IIb increases expression EXP Cephaloridine results in increased expression of FCGR2B mRNA CTD PMID:18500788 NCBI chr13:89,329,298...89,343,916
Ensembl chr13:89,327,794...89,433,815 		JBrowse link
G Fcgr3a Fc fragment of IgG receptor IIIa increases expression EXP Cephaloridine results in increased expression of FCGR3A mRNA CTD PMID:18500788 NCBI chr13:89,385,775...89,396,047
Ensembl chr13:89,385,859...89,396,051 		JBrowse link
G Fcnb ficolin B increases expression EXP Cephaloridine results in increased expression of FCNB mRNA CTD PMID:18500788 NCBI chr 3:6,617,816...6,626,193
Ensembl chr 3:6,617,751...6,626,284 		JBrowse link
G Fen1 flap structure-specific endonuclease 1 increases expression EXP Cephaloridine results in increased expression of FEN1 mRNA CTD PMID:18500788 NCBI chr 1:226,251,516...226,256,160
Ensembl chr 1:226,251,518...226,255,886 		JBrowse link
G Fgb fibrinogen beta chain increases expression EXP Cephaloridine results in increased expression of FGB mRNA CTD PMID:18500788 NCBI chr 2:182,028,044...182,035,026
Ensembl chr 2:182,027,115...182,038,178 		JBrowse link
G Fgf17 fibroblast growth factor 17 increases expression EXP Cephaloridine results in increased expression of FGF17 mRNA CTD PMID:18500788 NCBI chr15:52,326,758...52,337,360
Ensembl chr15:52,326,778...52,332,097 		JBrowse link
G Fgl2 fibrinogen-like 2 increases expression EXP Cephaloridine results in increased expression of FGL2 mRNA CTD PMID:18500788 NCBI chr 4:10,323,598...10,329,241
Ensembl chr 4:10,323,607...10,329,241 		JBrowse link
G Fhdc1 FH2 domain containing 1 increases expression EXP Cephaloridine results in increased expression of FHDC1 mRNA CTD PMID:18500788 NCBI chr 2:183,450,608...183,487,820
Ensembl chr 2:183,450,619...183,487,820 		JBrowse link
G Filip1 filamin A interacting protein 1 decreases expression EXP Cephaloridine results in decreased expression of FILIP1 mRNA CTD PMID:18500788 NCBI chr 8:87,257,312...87,453,432
Ensembl chr 8:87,256,264...87,419,564 		JBrowse link
G Folh1 folate hydrolase 1 decreases expression EXP Cephaloridine results in decreased expression of FOLH1 mRNA CTD PMID:18500788 NCBI chr 1:150,323,768...150,395,415
Ensembl chr 1:150,323,768...150,395,415 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit decreases expression EXP Cephaloridine results in decreased expression of FOS mRNA CTD PMID:18500788 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299 		JBrowse link
G Foxe1 forkhead box E1 decreases expression EXP Cephaloridine results in decreased expression of FOXE1 mRNA CTD PMID:18500788 NCBI chr 5:61,954,549...61,957,357
Ensembl chr 5:61,954,549...61,957,357 		JBrowse link
G Foxq1 forkhead box Q1 increases expression EXP Cephaloridine results in increased expression of FOXQ1 mRNA CTD PMID:18500788 NCBI chr17:34,224,308...34,226,941
Ensembl chr17:34,224,818...34,226,453 		JBrowse link
G Fyco1 FYVE and coiled-coil domain autophagy adaptor 1 decreases expression EXP Cephaloridine results in decreased expression of FYCO1 mRNA CTD PMID:18500788 NCBI chr 8:132,844,042...132,910,905
Ensembl chr 8:132,844,043...132,911,193 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 decreases expression EXP Cephaloridine results in decreased expression of G6PC1 mRNA CTD PMID:18500788 NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213 		JBrowse link
G G6pd glucose-6-phosphate dehydrogenase increases expression EXP Cephaloridine results in increased expression of G6PD mRNA CTD PMID:18500788 NCBI chr  X:156,274,800...156,293,935
Ensembl chr  X:156,274,800...156,293,926 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression EXP Cephaloridine results in increased expression of GADD45A mRNA CTD PMID:18172885 NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842 		JBrowse link
G Galnt13 polypeptide N-acetylgalactosaminyltransferase 13 increases expression EXP Cephaloridine results in increased expression of GALNT13 mRNA CTD PMID:18500788 NCBI chr 3:39,967,056...40,625,144
Ensembl chr 3:40,038,336...40,624,530 		JBrowse link
G Ganc glucosidase, alpha; neutral C decreases expression EXP Cephaloridine results in decreased expression of GANC mRNA CTD PMID:18500788 NCBI chr 3:112,173,907...112,226,886
Ensembl chr 3:112,173,907...112,226,023 		JBrowse link
G Gba3 glucosylceramidase beta 3 decreases expression EXP Cephaloridine results in decreased expression of GBA3 mRNA CTD PMID:18500788 NCBI chr14:64,390,793...64,535,213
Ensembl chr14:64,390,793...64,535,170 		JBrowse link
G Gda guanine deaminase increases expression EXP Cephaloridine results in increased expression of GDA mRNA CTD PMID:18500788 NCBI chr 1:238,982,542...239,057,663
Ensembl chr 1:238,982,392...239,057,732 		JBrowse link
G Gdf15 growth differentiation factor 15 decreases expression EXP Cephaloridine results in decreased expression of GDF15 mRNA CTD PMID:18500788 NCBI chr16:20,555,395...20,557,978
Ensembl chr16:20,555,395...20,557,978 		JBrowse link
G Gfra2 GDNF family receptor alpha 2 decreases expression EXP Cephaloridine results in decreased expression of GFRA2 mRNA CTD PMID:18500788 NCBI chr15:52,557,004...52,648,984
Ensembl chr15:52,557,607...52,648,972 		JBrowse link
G Gins2 GINS complex subunit 2 increases expression EXP Cephaloridine results in increased expression of GINS2 mRNA CTD PMID:18500788 NCBI chr19:54,151,048...54,163,701
Ensembl chr19:54,151,048...54,163,608 		JBrowse link
G Gins4 GINS complex subunit 4 increases expression EXP Cephaloridine results in increased expression of GINS4 mRNA CTD PMID:18500788 NCBI chr16:73,584,412...73,596,808
Ensembl chr16:73,584,521...73,596,793 		JBrowse link
G Gmnn geminin, DNA replication inhibitor increases expression EXP Cephaloridine results in increased expression of GMNN mRNA CTD PMID:18500788 NCBI chr17:42,302,523...42,310,783
Ensembl chr17:42,302,540...42,310,783 		JBrowse link
G Gna14 G protein subunit alpha 14 increases expression EXP Cephaloridine results in increased expression of GNA14 mRNA CTD PMID:18500788 NCBI chr 1:235,165,775...235,347,986
Ensembl chr 1:235,166,718...235,347,937 		JBrowse link
G Gpnmb glycoprotein nmb increases expression EXP Cephaloridine results in increased expression of GPNMB mRNA CTD PMID:18500788 NCBI chr 4:78,694,447...78,715,685
Ensembl chr 4:78,694,447...78,715,683 		JBrowse link
G Gpr135 G protein-coupled receptor 135 decreases expression EXP Cephaloridine results in decreased expression of GPR135 mRNA CTD PMID:18500788 NCBI chr 6:94,816,976...94,818,349
Ensembl chr 6:94,816,976...94,818,349 		JBrowse link
G Gpr19 G protein-coupled receptor 19 increases expression EXP Cephaloridine results in increased expression of GPR19 mRNA CTD PMID:18500788 NCBI chr 4:168,639,930...168,668,345
Ensembl chr 4:168,639,940...168,656,673 		JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression EXP Cephaloridine results in increased expression of GPX2 mRNA CTD PMID:18500788 NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245 		JBrowse link
G Gria3 glutamate ionotropic receptor AMPA type subunit 3 decreases expression EXP Cephaloridine results in decreased expression of GRIA3 mRNA CTD PMID:18500788 NCBI chr  X:127,561,843...127,829,763
Ensembl chr  X:127,562,660...127,829,753 		JBrowse link
G Gsr glutathione-disulfide reductase increases expression EXP Cephaloridine results in increased expression of GSR mRNA CTD PMID:18172885 NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361 		JBrowse link
G Gsta2 glutathione S-transferase alpha 2 increases expression EXP Cephaloridine results in increased expression of GSTA2 mRNA CTD PMID:18172885 NCBI chr 8:85,640,081...85,645,621 JBrowse link
G Gsta5 glutathione S-transferase alpha 5 increases expression EXP Cephaloridine results in increased expression of GSTA5 mRNA CTD PMID:18172885 NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 increases expression EXP Cephaloridine results in increased expression of GSTM1 mRNA CTD PMID:18172885 PMID:18500788 NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 increases expression EXP Cephaloridine results in increased expression of GSTP1 mRNA CTD PMID:18500788 NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147 		JBrowse link
G Gxylt1 glucoside xylosyltransferase 1 decreases expression EXP Cephaloridine results in decreased expression of GXYLT1 mRNA CTD PMID:18500788 NCBI chr 7:134,447,578...134,495,858
Ensembl chr 7:134,447,578...134,495,835 		JBrowse link
G H1f1 H1.1 linker histone, cluster member increases expression EXP Cephaloridine results in increased expression of H1F1 mRNA CTD PMID:18500788 NCBI chr17:43,614,101...43,614,844
Ensembl chr17:43,614,101...43,614,844 		JBrowse link
G Hadh hydroxyacyl-CoA dehydrogenase decreases expression EXP Cephaloridine results in decreased expression of HADH mRNA CTD PMID:18500788 NCBI chr 2:236,353,445...236,395,067
Ensembl chr 2:236,353,445...236,395,067 		JBrowse link
G Haus8 HAUS augmin-like complex, subunit 8 increases expression EXP Cephaloridine results in increased expression of HAUS8 mRNA CTD PMID:18500788 NCBI chr16:19,654,785...19,669,221
Ensembl chr16:19,654,798...19,669,196 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 increases expression EXP Cephaloridine results in increased expression of HAVCR1 mRNA CTD PMID:18500788 PMID:20305092 NCBI chr10:31,813,819...31,860,934
Ensembl chr10:31,813,814...31,848,379 		JBrowse link
G Hck HCK proto-oncogene, Src family tyrosine kinase increases expression EXP Cephaloridine results in increased expression of HCK mRNA CTD PMID:18500788 NCBI chr 3:148,579,917...148,623,026
Ensembl chr 3:148,579,920...148,623,033 		JBrowse link
G Hebp1 heme binding protein 1 increases expression EXP Cephaloridine results in increased expression of HEBP1 mRNA CTD PMID:18500788 NCBI chr 4:168,903,586...168,933,102
Ensembl chr 4:168,903,565...168,933,079 		JBrowse link
G Hebp2 heme binding protein 2 increases expression EXP Cephaloridine results in increased expression of HEBP2 mRNA CTD PMID:18500788 NCBI chr 1:13,713,152...13,719,970
Ensembl chr 1:13,714,440...13,719,829 		JBrowse link
G Hells helicase, lymphoid specific increases expression EXP Cephaloridine results in increased expression of HELLS mRNA CTD PMID:18500788 NCBI chr 1:257,901,856...257,953,889
Ensembl chr 1:257,766,691...257,949,183
Ensembl chr 1:257,766,691...257,949,183 		JBrowse link
G Hepacam2 HEPACAM family member 2 increases expression EXP Cephaloridine results in increased expression of HEPACAM2 mRNA CTD PMID:18500788 NCBI chr 4:28,402,862...28,437,722
Ensembl chr 4:28,403,125...28,437,676 		JBrowse link
G Hjv hemojuvelin BMP co-receptor decreases expression EXP Cephaloridine results in decreased expression of HJV mRNA CTD PMID:18500788 NCBI chr 2:198,655,437...198,659,318
Ensembl chr 2:198,655,437...198,659,317 		JBrowse link
G Hlx H2.0-like homeobox decreases expression EXP Cephaloridine results in decreased expression of HLX mRNA CTD PMID:18500788 NCBI chr13:102,637,967...102,643,376
Ensembl chr13:102,637,769...102,643,223 		JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 decreases expression EXP Cephaloridine results in decreased expression of HMGCS2 mRNA CTD PMID:18500788 NCBI chr 2:200,452,623...200,480,785
Ensembl chr 2:200,452,624...200,479,423 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression EXP Cephaloridine results in increased expression of HMOX1 mRNA CTD PMID:18172885 PMID:18500788 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456 		JBrowse link
G Hmx3 H6 family homeobox 3 increases expression EXP Cephaloridine results in increased expression of HMX3 mRNA CTD PMID:18500788 NCBI chr 1:203,509,731...203,511,695
Ensembl chr 1:203,509,731...203,511,695 		JBrowse link
G Hnrnpa1 heterogeneous nuclear ribonucleoprotein A1 increases expression EXP Cephaloridine results in increased expression of HNRNPA1 mRNA CTD PMID:18500788 NCBI chr 7:144,865,302...144,871,592
Ensembl chr 7:144,865,608...144,871,585 		JBrowse link
G Hrg histidine-rich glycoprotein decreases expression EXP Cephaloridine results in decreased expression of HRG mRNA CTD PMID:18500788 NCBI chr11:81,621,274...81,639,938
Ensembl chr11:81,621,283...81,639,952 		JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 decreases expression EXP Cephaloridine results in decreased expression of HSD17B2 mRNA CTD PMID:18500788 NCBI chr19:50,246,404...50,317,892
Ensembl chr19:50,246,402...50,317,891 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 increases expression EXP Cephaloridine results in increased expression of HSD3B1 mRNA CTD PMID:18500788
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 increases expression EXP Cephaloridine results in increased expression of HSP90AA1 mRNA CTD PMID:18500788 NCBI chr 6:135,107,262...135,112,793
Ensembl chr 6:135,107,271...135,112,775 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A increases expression EXP Cephaloridine results in increased expression of HSPA1A mRNA CTD PMID:18500788 NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B increases expression EXP Cephaloridine results in increased expression of HSPA1B mRNA CTD PMID:18500788 NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815 		JBrowse link
G Hsph1 heat shock protein family H (Hsp110) member 1 increases expression EXP Cephaloridine results in increased expression of HSPH1 mRNA CTD PMID:18500788 NCBI chr12:6,322,685...6,341,898
Ensembl chr12:6,322,668...6,341,902 		JBrowse link
G Htatip2 HIV-1 Tat interactive protein 2 increases expression EXP Cephaloridine results in increased expression of HTATIP2 mRNA CTD PMID:18500788 NCBI chr 1:105,094,272...105,109,459
Ensembl chr 1:105,094,411...105,109,461 		JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression EXP Cephaloridine results in increased expression of ICAM1 mRNA CTD PMID:18500788 NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059 		JBrowse link
G Ier3 immediate early response 3 decreases expression EXP Cephaloridine results in decreased expression of IER3 mRNA CTD PMID:18500788 NCBI chr20:3,438,798...3,440,002
Ensembl chr20:3,438,798...3,440,769 		JBrowse link
G Ifitm10 interferon induced transmembrane protein 10 increases expression EXP Cephaloridine results in increased expression of IFITM10 mRNA CTD PMID:18500788 NCBI chr 1:215,521,604...215,538,283
Ensembl chr 1:215,515,764...215,536,980 		JBrowse link
G Il18 interleukin 18 increases expression EXP Cephaloridine results in increased expression of IL18 mRNA CTD PMID:18500788 NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299 		JBrowse link
G Il1b interleukin 1 beta decreases expression EXP Cephaloridine results in decreased expression of IL1B mRNA CTD PMID:18500788 NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726 		JBrowse link
G Il20ra interleukin 20 receptor subunit alpha decreases expression EXP Cephaloridine results in decreased expression of IL20RA mRNA CTD PMID:18500788 NCBI chr 1:15,180,328...15,222,785
Ensembl chr 1:15,180,328...15,222,785 		JBrowse link
G Inhbb inhibin subunit beta B decreases expression EXP Cephaloridine results in decreased expression of INHBB mRNA CTD PMID:18500788 NCBI chr13:35,436,532...35,442,222
Ensembl chr13:35,436,532...35,442,222 		JBrowse link
G Itpka inositol-trisphosphate 3-kinase A increases expression EXP Cephaloridine results in increased expression of ITPKA mRNA CTD PMID:18500788 NCBI chr 3:111,545,007...111,553,605
Ensembl chr 3:111,545,007...111,553,604 		JBrowse link
G Itpkb inositol-trisphosphate 3-kinase B increases expression EXP Cephaloridine results in increased expression of ITPKB mRNA CTD PMID:18500788 NCBI chr13:98,615,287...98,710,426
Ensembl chr13:98,615,287...98,708,149 		JBrowse link
G Jade2 jade family PHD finger 2 decreases expression EXP Cephaloridine results in decreased expression of JADE2 mRNA CTD PMID:18500788 NCBI chr10:37,269,132...37,315,638
Ensembl chr10:37,270,183...37,311,625 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression EXP Cephaloridine results in increased expression of JUN mRNA CTD PMID:18172885 NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277 		JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit decreases expression
increases expression		 EXP Cephaloridine results in decreased expression of JUNB mRNA
Cephaloridine results in increased expression of JUNB mRNA		 CTD PMID:18172885 PMID:18500788 NCBI chr19:26,092,972...26,094,756
Ensembl chr19:26,092,974...26,094,756 		JBrowse link
G Kbtbd11 kelch repeat and BTB domain containing 11 decreases expression EXP Cephaloridine results in decreased expression of KBTBD11 mRNA CTD PMID:18500788 NCBI chr16:79,696,395...79,716,129
Ensembl chr16:79,696,891...79,700,992 		JBrowse link
G Kcnh1 potassium voltage-gated channel subfamily H member 1 increases expression EXP Cephaloridine results in increased expression of KCNH1 mRNA CTD PMID:18500788 NCBI chr13:110,920,712...111,232,291
Ensembl chr13:110,920,737...111,232,269 		JBrowse link
G Kcnj15 potassium inwardly-rectifying channel, subfamily J, member 15 decreases expression EXP Cephaloridine results in decreased expression of KCNJ15 mRNA CTD PMID:18500788 NCBI chr11:35,545,185...35,588,517
Ensembl chr11:35,568,182...35,585,390 		JBrowse link
G Kctd1 potassium channel tetramerization domain containing 1 increases expression EXP Cephaloridine results in increased expression of KCTD1 mRNA CTD PMID:18500788 NCBI chr18:6,374,778...6,474,990
Ensembl chr18:6,374,778...6,474,990 		JBrowse link
G Kif18a kinesin family member 18A decreases expression EXP Cephaloridine results in decreased expression of KIF18A mRNA CTD PMID:18500788 NCBI chr 3:100,366,168...100,426,867
Ensembl chr 3:100,366,168...100,427,030 		JBrowse link
G Kif2c kinesin family member 2C decreases expression EXP Cephaloridine results in decreased expression of KIF2C mRNA CTD PMID:18500788 NCBI chr 5:136,027,923...136,053,268
Ensembl chr 5:136,027,934...136,053,210 		JBrowse link
G Klf7 Kruppel like factor 7 decreases expression EXP Cephaloridine results in decreased expression of KLF7 mRNA CTD PMID:18500788 NCBI chr 9:70,740,480...70,787,913
Ensembl chr 9:70,740,480...70,787,913 		JBrowse link
G Klhl25 kelch-like family member 25 decreases expression EXP Cephaloridine results in decreased expression of KLHL25 mRNA CTD PMID:18500788 NCBI chr 1:137,333,880...137,359,107
Ensembl chr 1:137,333,881...137,359,072 		JBrowse link
G Knstrn kinetochore-localized astrin/SPAG5 binding protein decreases expression EXP Cephaloridine results in decreased expression of KNSTRN mRNA CTD PMID:18500788 NCBI chr 3:110,618,256...110,638,024
Ensembl chr 3:110,618,298...110,638,046 		JBrowse link
G Kntc1 kinetochore associated 1 increases expression EXP Cephaloridine results in increased expression of KNTC1 mRNA CTD PMID:18500788 NCBI chr12:38,200,463...38,274,162
Ensembl chr12:38,200,463...38,274,036 		JBrowse link
G Lama2 laminin subunit alpha 2 decreases expression EXP Cephaloridine results in decreased expression of LAMA2 mRNA CTD PMID:18500788 NCBI chr 1:18,491,264...19,143,486
Ensembl chr 1:18,491,384...19,143,269 		JBrowse link
G Lamb3 laminin subunit beta 3 increases expression EXP Cephaloridine results in increased expression of LAMB3 mRNA CTD PMID:18500788 NCBI chr13:112,031,614...112,073,187
Ensembl chr13:112,031,594...112,073,186 		JBrowse link
G Lars1 leucyl-tRNA synthetase 1 decreases expression EXP Cephaloridine results in decreased expression of LARS mRNA CTD PMID:18500788 NCBI chr18:36,524,013...36,579,471
Ensembl chr18:36,524,007...36,579,403 		JBrowse link
G Lcor ligand dependent nuclear receptor corepressor decreases expression EXP Cephaloridine results in decreased expression of LCOR mRNA CTD PMID:18500788 NCBI chr 1:260,775,091...260,839,549
Ensembl chr 1:260,732,485...260,830,854 		JBrowse link
G Lect2 leukocyte cell-derived chemotaxin 2 decreases expression EXP Cephaloridine results in decreased expression of LECT2 mRNA CTD PMID:18500788 NCBI chr17:8,489,261...8,495,483
Ensembl chr17:8,489,266...8,495,496 		JBrowse link
G Lgals2 galectin 2 increases expression EXP Cephaloridine results in increased expression of LGALS2 mRNA CTD PMID:18500788 NCBI chr 7:120,071,122...120,077,612
Ensembl chr 7:120,071,124...120,077,612 		JBrowse link
G Lgals3 galectin 3 increases expression EXP Cephaloridine results in increased expression of LGALS3 mRNA CTD PMID:18500788 NCBI chr15:24,153,602...24,165,537
Ensembl chr15:24,141,651...24,165,537 		JBrowse link
G Lhx3 LIM homeobox 3 decreases expression EXP Cephaloridine results in decreased expression of LHX3 mRNA CTD PMID:18500788 NCBI chr 3:3,653,861...3,662,509
Ensembl chr 3:3,654,755...3,661,810 		JBrowse link
G Lig1 DNA ligase 1 increases expression EXP Cephaloridine results in increased expression of LIG1 mRNA CTD PMID:18500788 NCBI chr 1:75,356,212...75,394,757
Ensembl chr 1:75,356,220...75,394,758 		JBrowse link
G Lmnb1 lamin B1 decreases expression EXP Cephaloridine results in decreased expression of LMNB1 mRNA CTD PMID:18500788 NCBI chr18:51,785,111...51,822,264
Ensembl chr18:51,785,111...51,822,264 		JBrowse link
G Lratd1 LRAT domain containing 1 increases expression EXP Cephaloridine results in increased expression of LRATD1 mRNA CTD PMID:18500788 NCBI chr 6:39,358,285...39,363,458
Ensembl chr 6:39,358,985...39,363,458 		JBrowse link
G Lrrn3 leucine rich repeat neuronal 3 decreases expression EXP Cephaloridine results in decreased expression of LRRN3 mRNA CTD PMID:18500788 NCBI chr 6:61,374,328...61,405,195
Ensembl chr 6:61,374,328...61,405,195 		JBrowse link
G Maf MAF bZIP transcription factor decreases expression EXP Cephaloridine results in decreased expression of MAF mRNA CTD PMID:18500788 NCBI chr19:48,179,826...48,200,995
Ensembl chr19:48,194,804...48,196,748 		JBrowse link
G Map3k1 mitogen-activated protein kinase kinase kinase 1 increases expression EXP Cephaloridine results in increased expression of MAP3K1 mRNA CTD PMID:18172885 NCBI chr 2:43,329,516...43,393,203
Ensembl chr 2:43,329,516...43,393,207 		JBrowse link
G Map3k12 mitogen activated protein kinase kinase kinase 12 decreases expression EXP Cephaloridine results in decreased expression of MAP3K12 mRNA CTD PMID:18172885 NCBI chr 7:144,102,275...144,120,306
Ensembl chr 7:144,102,680...144,109,116 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation
increases activity		 EXP Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK1 protein]
Cephaloridine results in increased activity of MAPK1 protein		 CTD PMID:16154539 PMID:16272694 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases activity
multiple interactions
increases phosphorylation		 EXP Cephaloridine results in increased activity of MAPK3 protein
Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK3 protein]		 CTD PMID:16154539 PMID:16272694 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975 		JBrowse link
G Mapk8ip3 mitogen-activated protein kinase 8 interacting protein 3 increases expression EXP Cephaloridine results in increased expression of MAPK8IP3 mRNA CTD PMID:18500788 NCBI chr10:14,259,394...14,299,276
Ensembl chr10:14,260,787...14,299,167 		JBrowse link
G Masp2 mannan-binding lectin serine peptidase 2 increases expression EXP Cephaloridine results in increased expression of MASP2 mRNA CTD PMID:18500788 NCBI chr 5:165,415,105...165,429,857
Ensembl chr 5:165,415,136...165,430,054 		JBrowse link
G Mcm2 minichromosome maintenance complex component 2 increases expression EXP Cephaloridine results in increased expression of MCM2 mRNA CTD PMID:18500788 NCBI chr 4:120,825,699...120,840,221
Ensembl chr 4:120,825,699...120,840,111 		JBrowse link
G Mcm3 minichromosome maintenance complex component 3 increases expression EXP Cephaloridine results in increased expression of MCM3 mRNA CTD PMID:18500788 NCBI chr 9:26,914,057...26,932,201
Ensembl chr 9:26,914,057...26,932,201 		JBrowse link
G Mcm5 minichromosome maintenance complex component 5 increases expression EXP Cephaloridine results in increased expression of MCM5 mRNA CTD PMID:18500788 NCBI chr19:14,523,482...14,561,281
Ensembl chr19:14,523,554...14,561,278 		JBrowse link
G Mcm6 minichromosome maintenance complex component 6 increases expression EXP Cephaloridine results in increased expression of MCM6 mRNA CTD PMID:18500788 NCBI chr13:45,042,882...45,068,073
Ensembl chr13:45,042,882...45,068,077 		JBrowse link
G Mcm7 minichromosome maintenance complex component 7 increases expression EXP Cephaloridine results in increased expression of MCM7 mRNA CTD PMID:18500788 NCBI chr12:19,306,615...19,313,877
Ensembl chr12:19,306,607...19,314,016 		JBrowse link
G Mcm8 minichromosome maintenance 8 homologous recombination repair factor increases expression EXP Cephaloridine results in increased expression of MCM8 mRNA CTD PMID:18500788 NCBI chr 3:125,470,499...125,500,795
Ensembl chr 3:125,470,551...125,500,795 		JBrowse link
G Mesp1 mesoderm posterior bHLH transcription factor 1 decreases expression EXP Cephaloridine results in decreased expression of MESP1 mRNA CTD PMID:18500788 NCBI chr 1:141,532,390...141,533,908
Ensembl chr 1:141,532,390...141,533,908 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase increases expression EXP Cephaloridine results in increased expression of MET mRNA CTD PMID:18172885 NCBI chr 4:44,747,467...44,854,628
Ensembl chr 4:44,774,741...44,852,665 		JBrowse link
G Mgll monoglyceride lipase decreases expression EXP Cephaloridine results in decreased expression of MGLL mRNA CTD PMID:18500788 NCBI chr 4:120,671,436...120,773,458
Ensembl chr 4:120,671,489...120,771,088 		JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression EXP Cephaloridine results in decreased expression of MKI67 mRNA CTD PMID:18500788 NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454 		JBrowse link
G Mmp12 matrix metallopeptidase 12 increases expression EXP Cephaloridine results in increased expression of MMP12 mRNA CTD PMID:18500788 NCBI chr 8:5,594,717...5,616,494
Ensembl chr 8:5,606,592...5,616,493 		JBrowse link
G Mmp16 matrix metallopeptidase 16 increases expression EXP Cephaloridine results in increased expression of MMP16 mRNA CTD PMID:18500788 NCBI chr 5:31,568,344...31,818,368
Ensembl chr 5:31,568,419...31,810,484 		JBrowse link
G Mnd1 meiotic nuclear divisions 1 increases expression EXP Cephaloridine results in increased expression of MND1 mRNA CTD PMID:18500788 NCBI chr 2:183,073,029...183,140,768
Ensembl chr 2:183,073,187...183,128,932 		JBrowse link
G Mns1 meiosis-specific nuclear structural 1 decreases expression EXP Cephaloridine results in decreased expression of MNS1 mRNA CTD PMID:18500788 NCBI chr 8:79,054,240...79,075,119
Ensembl chr 8:79,054,237...79,075,122 		JBrowse link
G Mpst mercaptopyruvate sulfurtransferase decreases expression EXP Cephaloridine results in decreased expression of MPST mRNA CTD PMID:18500788 NCBI chr 7:119,626,636...119,631,317
Ensembl chr 7:119,626,637...119,631,425 		JBrowse link
G Mpv17l MPV17 mitochondrial inner membrane protein like decreases expression EXP Cephaloridine results in decreased expression of MPV17L mRNA CTD PMID:18500788 NCBI chr10:3,321,488...3,359,219
Ensembl chr10:3,321,476...3,357,470 		JBrowse link
G Mrps36 mitochondrial ribosomal protein S36 increases expression EXP Cephaloridine results in increased expression of MRPS36 mRNA CTD PMID:18500788 NCBI chr 2:30,740,620...30,750,916
Ensembl chr 2:30,739,855...30,748,428 		JBrowse link
G Mt1 metallothionein 1 decreases expression EXP Cephaloridine results in decreased expression of MT1A mRNA CTD PMID:18172885 NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724 		JBrowse link
G Mthfd1l methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like increases expression EXP Cephaloridine results in increased expression of MTHFD1L mRNA CTD PMID:18500788 NCBI chr 1:40,529,092...40,719,232
Ensembl chr 1:40,529,045...40,719,391 		JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase increases expression EXP Cephaloridine results in increased expression of MTHFD2 mRNA CTD PMID:18500788 NCBI chr 4:115,004,433...115,015,965
Ensembl chr 4:115,004,448...115,015,965 		JBrowse link
G Myom3 myomesin 3 increases expression EXP Cephaloridine results in increased expression of MYOM3 mRNA CTD PMID:18500788 NCBI chr 5:154,109,293...154,159,943
Ensembl chr 5:154,112,076...154,159,601 		JBrowse link
G Ncor2 nuclear receptor co-repressor 2 decreases expression EXP Cephaloridine results in decreased expression of NCOR2 mRNA CTD PMID:18500788 NCBI chr12:36,871,917...37,033,701
Ensembl chr12:36,871,999...37,033,701 		JBrowse link
G Nek6 NIMA-related kinase 6 increases expression EXP Cephaloridine results in increased expression of NEK6 mRNA CTD PMID:18500788 NCBI chr 3:22,811,927...22,888,598
Ensembl chr 3:22,811,927...22,888,598 		JBrowse link
G Nfil3 nuclear factor, interleukin 3 regulated increases expression EXP Cephaloridine results in increased expression of NFIL3 mRNA CTD PMID:18500788 NCBI chr17:12,261,102...12,276,316
Ensembl chr17:12,261,102...12,276,315 		JBrowse link
G Nfkbia NFKB inhibitor alpha decreases expression EXP Cephaloridine results in decreased expression of NFKBIA mRNA CTD PMID:18172885 NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457 		JBrowse link
G Nfkbiz NFKB inhibitor zeta decreases expression EXP Cephaloridine results in decreased expression of NFKBIZ mRNA CTD PMID:18500788 NCBI chr11:47,243,342...47,271,487
Ensembl chr11:47,243,342...47,271,487 		JBrowse link
G Ngfr nerve growth factor receptor increases expression EXP Cephaloridine results in increased expression of NGFR mRNA CTD PMID:18500788 NCBI chr10:83,389,828...83,408,061
Ensembl chr10:83,389,847...83,408,061 		JBrowse link
G Nhp2 NHP2 ribonucleoprotein increases expression EXP Cephaloridine results in increased expression of NHP2 mRNA CTD PMID:18500788 NCBI chr10:34,975,701...34,979,082
Ensembl chr10:34,975,708...34,979,082 		JBrowse link
G Ninj2 ninjurin 2 increases expression EXP Cephaloridine results in increased expression of NINJ2 mRNA CTD PMID:18500788 NCBI chr 4:152,630,464...152,733,631
Ensembl chr 4:152,630,469...152,733,633 		JBrowse link
G Nipsnap3b nipsnap homolog 3B increases expression EXP Cephaloridine results in increased expression of NIPSNAP3B mRNA CTD PMID:18500788 NCBI chr 5:69,833,200...69,849,116
Ensembl chr 5:69,833,225...69,849,112 		JBrowse link
G Nme4 NME/NM23 nucleoside diphosphate kinase 4 decreases expression EXP Cephaloridine results in decreased expression of NME4 mRNA CTD PMID:18500788 NCBI chr10:15,461,567...15,465,422
Ensembl chr10:15,431,638...15,465,413 		JBrowse link
G Nop56 NOP56 ribonucleoprotein increases expression EXP Cephaloridine results in increased expression of NOP56 mRNA CTD PMID:18500788 NCBI chr 3:122,803,726...122,808,564
Ensembl chr 3:122,803,772...122,808,558 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression EXP Cephaloridine results in increased expression of NQO1 mRNA CTD PMID:18172885 PMID:18500788 NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180 		JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 increases expression EXP Cephaloridine results in increased expression of NR1D1 mRNA CTD PMID:18500788 NCBI chr10:86,683,875...86,690,815
Ensembl chr10:86,683,875...86,690,815 		JBrowse link
G Nrm nurim increases expression EXP Cephaloridine results in increased expression of NRM mRNA CTD PMID:18500788 NCBI chr20:3,397,834...3,402,264
Ensembl chr20:3,397,834...3,401,315 		JBrowse link
G Nudt11 nudix hydrolase 11 increases expression EXP Cephaloridine results in increased expression of NUDT10 mRNA; Cephaloridine results in increased expression of NUDT11 mRNA CTD PMID:18500788 NCBI chr  X:17,171,510...17,215,108
Ensembl chr  X:17,540,458...17,540,952
Ensembl chr  X:17,540,458...17,540,952 		JBrowse link
G Olr110 olfactory receptor 110 decreases expression EXP Cephaloridine results in decreased expression of OLR110 mRNA CTD PMID:18500788 NCBI chr 1:168,655,404...168,656,369
Ensembl chr 1:168,655,404...168,656,369 		JBrowse link
G Olr1583 olfactory receptor 1583 increases expression EXP Cephaloridine results in increased expression of OLR1583 mRNA CTD PMID:18500788 NCBI chr13:91,725,324...91,726,265
Ensembl chr13:91,725,324...91,726,265 		JBrowse link
G Olr16 olfactory receptor 16 decreases expression EXP Cephaloridine results in decreased expression of OLR16 mRNA CTD PMID:18500788 NCBI chr 1:149,674,493...149,675,443
Ensembl chr 1:149,674,493...149,675,443 		JBrowse link
G Olr1657 olfactory receptor 1657 increases expression EXP Cephaloridine results in increased expression of OLR1657 mRNA CTD PMID:18500788
G Olr202 olfactory receptor 202 increases expression EXP Cephaloridine results in increased expression of OLR202 mRNA CTD PMID:18500788 NCBI chr 1:170,185,494...170,186,462
Ensembl chr 1:170,185,494...170,186,462 		JBrowse link
G Olr390 olfactory receptor 390 decreases expression EXP Cephaloridine results in decreased expression of OLR390 mRNA CTD PMID:18500788 NCBI chr 2:199,528,902...199,529,864
Ensembl chr 2:199,528,902...199,529,864 		JBrowse link
G Olr46 olfactory receptor 46 decreases expression EXP Cephaloridine results in decreased expression of OLR46 mRNA CTD PMID:18500788 NCBI chr 1:167,758,636...167,759,580
Ensembl chr 1:167,758,636...167,759,580 		JBrowse link
G Oprl1 opioid related nociceptin receptor 1 increases expression EXP Cephaloridine results in increased expression of OPRL1 mRNA CTD PMID:18500788 NCBI chr 3:177,223,779...177,231,663
Ensembl chr 3:177,225,737...177,231,663 		JBrowse link
G Orc6 origin recognition complex, subunit 6 increases expression EXP Cephaloridine results in increased expression of ORC6 mRNA CTD PMID:18500788 NCBI chr19:27,457,541...27,464,804
Ensembl chr19:27,457,474...27,464,805 		JBrowse link
G Osbpl8 oxysterol binding protein-like 8 decreases expression EXP Cephaloridine results in decreased expression of OSBPL8 mRNA CTD PMID:18500788 NCBI chr 7:53,878,906...54,030,110
Ensembl chr 7:53,878,610...54,027,892 		JBrowse link
G Osmr oncostatin M receptor increases expression EXP Cephaloridine results in increased expression of OSMR mRNA CTD PMID:18500788 NCBI chr 2:56,107,491...56,163,522
Ensembl chr 2:56,110,777...56,151,531 		JBrowse link
G Oxgr1 oxoglutarate receptor 1 increases expression EXP Cephaloridine results in increased expression of OXGR1 mRNA CTD PMID:18500788 NCBI chr15:105,399,596...105,422,559
Ensembl chr15:105,401,695...105,402,708 		JBrowse link
G Padi6 peptidyl arginine deiminase 6 increases expression EXP Cephaloridine results in increased expression of PADI6 mRNA CTD PMID:18500788 NCBI chr 5:159,241,276...159,256,749
Ensembl chr 5:159,241,413...159,256,699 		JBrowse link
G Palb2 partner and localizer of BRCA2 increases expression EXP Cephaloridine results in increased expression of PALB2 mRNA CTD PMID:18500788 NCBI chr 1:192,064,586...192,088,547
Ensembl chr 1:192,064,589...192,088,520 		JBrowse link
G Pask PAS domain containing serine/threonine kinase increases expression EXP Cephaloridine results in increased expression of PASK mRNA CTD PMID:18500788 NCBI chr 9:100,450,595...100,479,719
Ensembl chr 9:100,450,586...100,479,868 		JBrowse link
G Pbk PDZ binding kinase decreases expression EXP Cephaloridine results in decreased expression of PBK mRNA CTD PMID:18500788 NCBI chr15:42,489,253...42,500,377
Ensembl chr15:42,489,377...42,500,395 		JBrowse link
G Pcdh7 protocadherin 7 decreases expression EXP Cephaloridine results in decreased expression of PCDH7 mRNA CTD PMID:18500788 NCBI chr14:54,649,054...55,081,632
Ensembl chr14:55,072,200...55,081,551 		JBrowse link
G Pcdh9 protocadherin 9 decreases expression EXP Cephaloridine results in decreased expression of PCDH9 mRNA CTD PMID:18500788 NCBI chr15:76,787,108...77,738,668
Ensembl chr15:77,733,402...77,736,892 		JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 decreases expression EXP Cephaloridine results in decreased expression of PCK1 mRNA CTD PMID:18500788 NCBI chr 3:171,213,936...171,219,885
Ensembl chr 3:171,213,936...171,219,871 		JBrowse link
G Pclaf PCNA clamp associated factor increases expression EXP Cephaloridine results in increased expression of PCLAF mRNA CTD PMID:18500788 NCBI chr 8:71,514,281...71,526,182
Ensembl chr 8:71,514,281...71,526,182 		JBrowse link
G Pcna proliferating cell nuclear antigen increases expression EXP Cephaloridine results in increased expression of PCNA mRNA CTD PMID:18500788 NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570 		JBrowse link
G Pdia4 protein disulfide isomerase family A, member 4 increases expression EXP Cephaloridine results in increased expression of PDIA4 mRNA CTD PMID:18172885 NCBI chr 4:77,470,636...77,489,535
Ensembl chr 4:77,470,636...77,489,535 		JBrowse link
G Pfn3 profilin 3 decreases expression EXP Cephaloridine results in decreased expression of PFN3 mRNA CTD PMID:18500788 NCBI chr17:9,746,485...9,747,012
Ensembl chr17:9,746,485...9,747,012 		JBrowse link
G Pipox pipecolic acid and sarcosine oxidase increases expression EXP Cephaloridine results in increased expression of PIPOX mRNA CTD PMID:18500788 NCBI chr10:64,951,986...64,964,865
Ensembl chr10:64,952,119...64,964,862 		JBrowse link
G Pir pirin increases expression EXP Cephaloridine results in increased expression of PIR mRNA CTD PMID:18500788 NCBI chr  X:31,852,322...31,968,152
Ensembl chr  X:31,852,323...31,968,152 		JBrowse link
G Pkhd1 PKHD1 ciliary IPT domain containing fibrocystin/polyductin decreases expression EXP Cephaloridine results in decreased expression of PKHD1 mRNA CTD PMID:18500788 NCBI chr 9:26,164,969...26,736,704 JBrowse link
G Pkmyt1 protein kinase, membrane associated tyrosine/threonine 1 increases expression EXP Cephaloridine results in increased expression of PKMYT1 mRNA CTD PMID:18500788 NCBI chr10:13,061,077...13,072,277
Ensembl chr10:13,061,170...13,073,283 		JBrowse link
G Pla1a phospholipase A1 member A increases expression EXP Cephaloridine results in increased expression of PLA1A mRNA CTD PMID:18500788 NCBI chr11:64,882,024...64,919,714
Ensembl chr11:64,882,288...64,919,579 		JBrowse link
G Plek2 pleckstrin 2 increases expression EXP Cephaloridine results in increased expression of PLEK2 mRNA CTD PMID:18500788 NCBI chr 6:102,076,736...102,095,002
Ensembl chr 6:102,075,632...102,095,201 		JBrowse link
G Plekha5 pleckstrin homology domain containing A5 decreases expression EXP Cephaloridine results in decreased expression of PLEKHA5 mRNA CTD PMID:18500788 NCBI chr 4:174,605,462...174,774,692
Ensembl chr 4:174,605,476...174,774,693 		JBrowse link
G Plk1 polo-like kinase 1 decreases expression EXP Cephaloridine results in decreased expression of PLK1 mRNA CTD PMID:18500788 NCBI chr 1:192,115,990...192,125,969
Ensembl chr 1:192,115,966...192,125,989 		JBrowse link
G Pola2 DNA polymerase alpha 2, accessory subunit increases expression EXP Cephaloridine results in increased expression of POLA2 mRNA CTD PMID:18500788 NCBI chr 1:221,297,417...221,321,601
Ensembl chr 1:221,273,538...221,321,570 		JBrowse link
G Pold1 DNA polymerase delta 1, catalytic subunit increases expression EXP Cephaloridine results in increased expression of POLD1 mRNA CTD PMID:18500788 NCBI chr 1:100,538,066...100,554,105
Ensembl chr 1:100,537,900...100,554,488 		JBrowse link
G Pole DNA polymerase epsilon, catalytic subunit increases expression EXP Cephaloridine results in increased expression of POLE mRNA CTD PMID:18500788 NCBI chr12:52,403,533...52,452,075
Ensembl chr12:52,403,529...52,452,040 		JBrowse link
G Ppa1 inorganic pyrophosphatase 1 increases expression EXP Cephaloridine results in increased expression of PPA1 mRNA CTD PMID:18500788 NCBI chr20:31,265,519...31,292,451
Ensembl chr20:31,265,483...31,310,674 		JBrowse link
G Ppm1j protein phosphatase, Mg2+/Mn2+ dependent, 1J increases expression EXP Cephaloridine results in increased expression of PPM1J mRNA CTD PMID:18500788 NCBI chr 2:207,263,307...207,268,601
Ensembl chr 2:207,262,934...207,268,609 		JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A decreases expression EXP Cephaloridine results in decreased expression of PPP1R15A mRNA CTD PMID:18500788 NCBI chr 1:101,511,899...101,515,043
Ensembl chr 1:101,511,901...101,514,974 		JBrowse link
G Prc1 protein regulator of cytokinesis 1 decreases expression EXP Cephaloridine results in decreased expression of PRC1 mRNA CTD PMID:18500788 NCBI chr 1:142,087,181...142,108,746
Ensembl chr 1:142,087,208...142,108,746 		JBrowse link
G Prim1 DNA primase subunit 1 increases expression EXP Cephaloridine results in increased expression of PRIM1 mRNA CTD PMID:18500788 NCBI chr 7:2,435,524...2,451,169
Ensembl chr 7:2,435,553...2,451,165 		JBrowse link
G Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta increases expression EXP Cephaloridine results in increased expression of PRKAR1B mRNA CTD PMID:18500788 NCBI chr12:17,614,536...17,713,567
Ensembl chr12:17,614,632...17,712,373 		JBrowse link
G Prodh2 proline dehydrogenase 2 decreases expression EXP Cephaloridine results in decreased expression of PRODH2 mRNA CTD PMID:18500788 NCBI chr 1:88,955,125...88,968,501
Ensembl chr 1:88,955,135...88,968,501 		JBrowse link
G Prrx1 paired related homeobox 1 decreases expression EXP Cephaloridine results in decreased expression of PRRX1 mRNA CTD PMID:18500788 NCBI chr13:81,147,038...81,215,559
Ensembl chr13:81,147,348...81,214,546 		JBrowse link
G Prss35 serine protease 35 decreases expression EXP Cephaloridine results in decreased expression of PRSS35 mRNA CTD PMID:18500788 NCBI chr 8:94,423,629...94,440,509
Ensembl chr 8:94,423,808...94,440,503 		JBrowse link
G Psmb4 proteasome 20S subunit beta 4 increases expression EXP Cephaloridine results in increased expression of PSMB4 mRNA CTD PMID:18172885 NCBI chr 2:196,043,546...196,046,320
Ensembl chr 2:196,043,618...196,046,311 		JBrowse link
G Ptbp1 polypyrimidine tract binding protein 1 increases expression EXP Cephaloridine results in increased expression of PTBP1 mRNA CTD PMID:18172885 NCBI chr 7:12,663,965...12,673,723
Ensembl chr 7:12,663,965...12,673,718 		JBrowse link
G Ptgr1 prostaglandin reductase 1 increases expression EXP Cephaloridine results in increased expression of PTGR1 mRNA CTD PMID:18500788 NCBI chr 5:76,110,746...76,129,361
Ensembl chr 5:76,110,738...76,129,441 		JBrowse link
G Ptpn11 protein tyrosine phosphatase, non-receptor type 11 decreases expression EXP Cephaloridine results in decreased expression of PTPN11 mRNA CTD PMID:18500788 NCBI chr12:40,895,515...40,955,999
Ensembl chr12:40,895,515...40,955,999 		JBrowse link
G Ptprb protein tyrosine phosphatase, receptor type, B decreases expression EXP Cephaloridine results in decreased expression of PTPRB mRNA CTD PMID:18500788 NCBI chr 7:59,326,484...59,431,114
Ensembl chr 7:59,326,518...59,425,718 		JBrowse link
G Ptprn2 protein tyrosine phosphatase, receptor type N2 increases expression EXP Cephaloridine results in increased expression of PTPRN2 mRNA CTD PMID:18500788 NCBI chr 6:144,384,773...145,133,042
Ensembl chr 6:144,384,773...145,133,042 		JBrowse link
G Ptrh1 peptidyl-tRNA hydrolase 1 homolog increases expression EXP Cephaloridine results in increased expression of PTRH1 mRNA CTD PMID:18500788 NCBI chr 3:11,811,303...11,817,007
Ensembl chr 3:11,811,962...11,825,640 		JBrowse link
G Pvr PVR cell adhesion molecule increases expression EXP Cephaloridine results in increased expression of PVR mRNA CTD PMID:18500788 NCBI chr 1:80,820,306...80,835,712
Ensembl chr 1:80,820,050...80,835,701 		JBrowse link
G Rab11fip3 RAB11 family interacting protein 3 decreases expression EXP Cephaloridine results in decreased expression of RAB11FIP3 mRNA CTD PMID:18500788 NCBI chr10:15,348,356...15,433,384
Ensembl chr10:15,349,888...15,381,691 		JBrowse link
G Rab31 RAB31, member RAS oncogene family decreases expression EXP Cephaloridine results in decreased expression of RAB31 mRNA CTD PMID:18500788 NCBI chr 9:113,370,072...113,504,606
Ensembl chr 9:113,370,033...113,504,605 		JBrowse link
G Rad18 RAD18 E3 ubiquitin protein ligase increases expression EXP Cephaloridine results in increased expression of RAD18 mRNA CTD PMID:18500788 NCBI chr 4:144,537,329...144,620,606
Ensembl chr 4:144,536,729...144,620,731 		JBrowse link
G Rb1 RB transcriptional corepressor 1 affects activity EXP Cephaloridine affects the activity of RB1 protein CTD PMID:18500788 NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342 		JBrowse link
G Rbp2 retinol binding protein 2 increases expression EXP Cephaloridine results in increased expression of RBP2 mRNA CTD PMID:18500788 NCBI chr 8:106,479,253...106,527,726
Ensembl chr 8:106,503,504...106,527,711 		JBrowse link
G Rbsn rabenosyn, RAB effector decreases expression EXP Cephaloridine results in decreased expression of RBSN mRNA CTD PMID:18500788 NCBI chr 4:124,050,559...124,080,919
Ensembl chr 4:124,052,300...124,080,906 		JBrowse link
G Rdh16 retinol dehydrogenase 16 decreases expression EXP Cephaloridine results in decreased expression of RDH2 mRNA CTD PMID:18500788 NCBI chr 7:71,058,150...71,072,685
Ensembl chr 7:70,980,422...71,072,689 		JBrowse link
G Recql4 RecQ like helicase 4 increases expression EXP Cephaloridine results in increased expression of RECQL4 mRNA CTD PMID:18500788 NCBI chr 7:117,765,892...117,773,128
Ensembl chr 7:117,763,783...117,773,134 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit affects activity EXP Cephaloridine affects the activity of RELA protein CTD PMID:18500788 NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249 		JBrowse link
G Rfc3 replication factor C subunit 3 increases expression EXP Cephaloridine results in increased expression of RFC3 mRNA CTD PMID:18500788 NCBI chr12:1,460,581...1,471,344
Ensembl chr12:1,460,538...1,471,357 		JBrowse link
G Rfc4 replication factor C subunit 4 increases expression EXP Cephaloridine results in increased expression of RFC4 mRNA CTD PMID:18500788 NCBI chr11:81,358,592...81,373,044
Ensembl chr11:81,358,592...81,373,043 		JBrowse link
G RGD1561843 similar to 60S ribosomal protein L23a increases expression EXP Cephaloridine results in increased expression of RGD1561843 mRNA CTD PMID:18500788 NCBI chr 1:1,677,753...1,678,254 JBrowse link
G RGD1561897 similar to Serine/threonine-protein kinase Kist (Kinase interacting with stathmin) increases expression EXP Cephaloridine results in increased expression of RGD1561897 mRNA CTD PMID:18500788 NCBI chr17:44,418,463...44,420,729 JBrowse link
G RGD1561944 similar to 60S ribosomal protein L32 decreases expression EXP Cephaloridine results in decreased expression of RGD1561944 mRNA CTD PMID:18500788 NCBI chr 8:91,300,451...91,301,003 JBrowse link
G RGD1562392 similar to Sulfotransferase K1 (rSULT1C2) decreases expression EXP Cephaloridine results in decreased expression of RGD1562392 mRNA CTD PMID:18500788 NCBI chr 9:4,241,300...4,623,136
Ensembl chr 9:4,081,457...4,280,794 		JBrowse link
G RGD1564040 similar to methylenetetrahydrofolate dehydrogenase (NAD) (EC 1.5.1.15)/methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9) precursor increases expression EXP Cephaloridine results in increased expression of RGD1564040 mRNA CTD PMID:18500788 NCBI chr 5:120,869,141...120,870,270 JBrowse link
G RGD1564324 similar to dehydrogenase/reductase member 2 increases expression EXP Cephaloridine results in increased expression of RGD1564324 mRNA CTD PMID:18500788 NCBI chr15:33,821,095...33,841,257
Ensembl chr15:33,822,730...33,825,620 		JBrowse link
G RGD1564606 similar to 60S ribosomal protein L23a increases expression EXP Cephaloridine results in increased expression of RGD1564606 mRNA CTD PMID:18500788 NCBI chr 2:38,230,697...38,231,287
Ensembl chr 2:38,230,757...38,231,227 		JBrowse link
G RGD1564866 similar to Heterogeneous nuclear ribonucleoprotein A1 (Helix-destabilizing protein) increases expression EXP Cephaloridine results in increased expression of RGD1564866 mRNA CTD PMID:18500788 NCBI chr  X:115,424,925...115,426,005 JBrowse link
G RGD1564999 similar to isopentenyl-diphosphate delta isomerase 2 decreases expression EXP Cephaloridine results in decreased expression of RGD1564999 mRNA CTD PMID:18500788 NCBI chr17:57,935,992...57,954,998 JBrowse link
G RGD1565017 similar to RS21-C6 protein increases expression EXP Cephaloridine results in increased expression of RGD1565017 mRNA CTD PMID:18500788 NCBI chr16:3,935,374...3,936,145 JBrowse link
G RGD1565166 similar to MGC45438 protein increases expression EXP Cephaloridine results in increased expression of RGD1565166 mRNA CTD PMID:18500788 NCBI chr10:10,555,337...10,564,433
Ensembl chr10:10,555,337...10,564,433 		JBrowse link
G Rgn regucalcin decreases expression EXP Cephaloridine results in decreased expression of RGN mRNA CTD PMID:8584014 PMID:18500788 NCBI chr  X:1,833,484...1,848,904
Ensembl chr  X:1,833,492...1,848,904 		JBrowse link
G Rgs11 regulator of G-protein signaling 11 increases expression EXP Cephaloridine results in increased expression of RGS11 mRNA CTD PMID:18500788
G Rhcg Rh family, C glycoprotein increases expression EXP Cephaloridine results in increased expression of RHCG mRNA CTD PMID:18500788 NCBI chr 1:141,325,854...141,349,881
Ensembl chr 1:141,325,856...141,349,881 		JBrowse link
G Rhobtb1 Rho-related BTB domain containing 1 decreases expression EXP Cephaloridine results in decreased expression of RHOBTB1 mRNA CTD PMID:18500788 NCBI chr20:20,638,579...20,715,437
Ensembl chr20:20,638,579...20,713,128 		JBrowse link
G Rhpn2 rhophilin, Rho GTPase binding protein 2 increases expression EXP Cephaloridine results in increased expression of RHPN2 mRNA CTD PMID:18500788 NCBI chr 1:91,596,344...91,657,395
Ensembl chr 1:91,596,397...91,657,395 		JBrowse link
G Rida reactive intermediate imine deaminase A homolog decreases expression EXP Cephaloridine results in decreased expression of RIDA mRNA CTD PMID:18500788 NCBI chr 7:73,256,506...73,270,308
Ensembl chr 7:73,256,508...73,270,308 		JBrowse link
G Rnd1 Rho family GTPase 1 increases expression EXP Cephaloridine results in increased expression of RND1 mRNA CTD PMID:18500788 NCBI chr 7:140,349,138...140,356,209
Ensembl chr 7:140,349,138...140,356,209 		JBrowse link
G Rnf227 ring finger protein 227 increases expression EXP Cephaloridine results in increased expression of RNF227 mRNA CTD PMID:18500788 NCBI chr10:55,940,533...55,941,205
Ensembl chr10:55,940,533...55,941,205 		JBrowse link
G Rpl23a ribosomal protein L23a increases expression EXP Cephaloridine results in increased expression of RPL23A mRNA CTD PMID:18500788 NCBI chr10:65,441,295...65,443,981
Ensembl chr10:65,441,295...65,443,981 		JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 decreases expression EXP Cephaloridine results in decreased expression of RRM2 mRNA CTD PMID:18500788 NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515 		JBrowse link
G Runx1t1 RUNX1 partner transcriptional co-repressor 1 decreases expression EXP Cephaloridine results in decreased expression of RUNX1T1 mRNA CTD PMID:18500788 NCBI chr 5:27,284,921...27,440,802
Ensembl chr 5:27,312,928...27,442,841 		JBrowse link
G Rxrg retinoid X receptor gamma increases expression EXP Cephaloridine results in increased expression of RXRG mRNA CTD PMID:18500788 NCBI chr13:85,818,473...85,868,555
Ensembl chr13:85,818,427...85,868,552 		JBrowse link
G Scgb3a1 secretoglobin, family 3A, member 1 increases expression EXP Cephaloridine results in increased expression of SCGB3A1 mRNA CTD PMID:18500788 NCBI chr10:35,133,561...35,134,868
Ensembl chr10:35,133,252...35,135,466 		JBrowse link
G Scgb3a2 secretoglobin, family 3A, member 2 increases expression EXP Cephaloridine results in increased expression of SCGB3A2 mRNA CTD PMID:18500788 NCBI chr18:38,292,822...38,295,744
Ensembl chr18:38,292,701...38,295,831 		JBrowse link
G Sct secretin increases expression EXP Cephaloridine results in increased expression of SCT mRNA CTD PMID:18500788 NCBI chr 1:214,264,865...214,277,437
Ensembl chr 1:214,264,754...214,265,668 		JBrowse link
G Sectm1b secreted and transmembrane 1B increases expression EXP Cephaloridine results in increased expression of SECTM1A mRNA CTD PMID:18500788 NCBI chr10:110,251,363...110,260,577
Ensembl chr10:110,251,363...110,259,985 		JBrowse link
G Selenop selenoprotein P decreases expression EXP Cephaloridine results in decreased expression of SELENOP mRNA CTD PMID:18500788 NCBI chr 2:53,105,912...53,116,198
Ensembl chr 2:53,109,684...53,114,858 		JBrowse link
G Sema4c semaphorin 4C decreases expression EXP Cephaloridine results in decreased expression of SEMA4C mRNA CTD PMID:18500788 NCBI chr 9:43,129,413...43,140,442
Ensembl chr 9:43,129,415...43,139,870 		JBrowse link
G Septin10 septin 10 decreases expression EXP Cephaloridine results in decreased expression of SEPTIN10 mRNA CTD PMID:18500788 NCBI chr20:28,722,479...28,814,841
Ensembl chr20:28,722,580...28,814,636 		JBrowse link
G Sh2b2 SH2B adaptor protein 2 increases expression EXP Cephaloridine results in increased expression of SH2B2 mRNA CTD PMID:18500788 NCBI chr12:23,471,477...23,501,043
Ensembl chr12:23,473,270...23,501,036 		JBrowse link
G Sh3bp2 SH3-domain binding protein 2 increases expression EXP Cephaloridine results in increased expression of SH3BP2 mRNA CTD PMID:18500788 NCBI chr14:81,435,445...81,473,013
Ensembl chr14:81,435,449...81,472,952 		JBrowse link
G Shroom4 shroom family member 4 decreases expression EXP Cephaloridine results in decreased expression of SHROOM4 mRNA CTD PMID:18500788 NCBI chr  X:16,723,360...16,929,829
Ensembl chr  X:16,719,803...16,929,907 		JBrowse link
G Ska1 spindle and kinetochore associated complex subunit 1 decreases expression EXP Cephaloridine results in decreased expression of SKA1 mRNA CTD PMID:18500788 NCBI chr18:70,174,316...70,184,368
Ensembl chr18:70,173,944...70,184,337 		JBrowse link
G Slc15a3 solute carrier family 15 member 3 increases expression EXP Cephaloridine results in increased expression of SLC15A3 mRNA CTD PMID:18500788 NCBI chr 1:226,896,387...226,912,644
Ensembl chr 1:226,897,625...226,912,708 		JBrowse link
G Slc16a12 solute carrier family 16, member 12 decreases expression EXP Cephaloridine results in decreased expression of SLC16A12 mRNA CTD PMID:18500788 NCBI chr 1:252,976,071...253,054,500
Ensembl chr 1:252,976,644...253,000,760 		JBrowse link
G Slc16a14 solute carrier family 16, member 14 decreases expression EXP Cephaloridine results in decreased expression of SLC16A14 mRNA CTD PMID:18500788 NCBI chr 9:92,503,602...92,531,163
Ensembl chr 9:92,503,597...92,530,938 		JBrowse link
G Slc1a5 solute carrier family 1 member 5 increases expression EXP Cephaloridine results in increased expression of SLC1A5 mRNA CTD PMID:18500788 NCBI chr 1:78,710,686...78,724,789
Ensembl chr 1:78,710,539...78,724,794 		JBrowse link
G Slc22a23 solute carrier family 22, member 23 decreases expression EXP Cephaloridine results in decreased expression of SLC22A23 mRNA CTD PMID:18500788 NCBI chr17:31,236,015...31,403,685
Ensembl chr17:31,236,015...31,403,685 		JBrowse link
G Slc22a5 solute carrier family 22 member 5 decreases expression EXP Cephaloridine results in decreased expression of SLC22A5 mRNA CTD PMID:18500788 NCBI chr10:39,201,101...39,228,090
Ensembl chr10:39,201,107...39,323,853 		JBrowse link
G Slc22a6 solute carrier family 22 member 6 increases import
multiple interactions
increases uptake		 EXP
ISO		 SLC22A6 protein results in increased import of Cephaloridine
Cephaloridine inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
SLC22A6 protein results in increased uptake of Cephaloridine		 CTD PMID:10594788 PMID:16098483 NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 increases uptake
multiple interactions		 ISO SLC22A8 protein results in increased uptake of Cephaloridine
Cephaloridine inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]		 CTD PMID:16098483 NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482 		JBrowse link
G Slc35d2 solute carrier family 35 member D2 increases expression EXP Cephaloridine results in increased expression of SLC35D2 mRNA CTD PMID:18500788 NCBI chr17:1,618,641...1,649,734
Ensembl chr17:1,618,189...1,648,973 		JBrowse link
G Slc39a4 solute carrier family 39 member 4 increases expression EXP Cephaloridine results in increased expression of SLC39A4 mRNA CTD PMID:18500788 NCBI chr 7:117,675,718...117,682,586
Ensembl chr 7:117,675,720...117,680,004 		JBrowse link
G Slc41a2 solute carrier family 41 member 2 increases expression EXP Cephaloridine results in increased expression of SLC41A2 mRNA CTD PMID:18500788 NCBI chr 7:26,522,314...26,607,861
Ensembl chr 7:26,522,314...26,607,861 		JBrowse link
G Slc46a3 solute carrier family 46, member 3 increases expression EXP Cephaloridine results in increased expression of SLC46A3 mRNA CTD PMID:18500788 NCBI chr12:8,725,479...8,741,944
Ensembl chr12:8,725,517...8,741,951 		JBrowse link
G Slc4a4 solute carrier family 4 member 4 decreases expression EXP Cephaloridine results in decreased expression of SLC4A4 mRNA CTD PMID:18500788 NCBI chr14:20,476,258...20,817,042
Ensembl chr14:20,479,323...20,920,286 		JBrowse link
G Slc5a3 solute carrier family 5 member 3 increases expression EXP Cephaloridine results in increased expression of SLC5A3 mRNA CTD PMID:18500788 NCBI chr11:32,229,366...32,231,812 JBrowse link
G Slc7a10 solute carrier family 7 member 10 increases expression EXP Cephaloridine results in increased expression of SLC7A10 mRNA CTD PMID:18500788 NCBI chr 1:91,432,952...91,448,566
Ensembl chr 1:91,433,030...91,448,564 		JBrowse link
G Slc7a5 solute carrier family 7 member 5 increases expression EXP Cephaloridine results in increased expression of SLC7A5 mRNA CTD PMID:18500788 NCBI chr19:54,693,959...54,722,563
Ensembl chr19:54,693,959...54,722,563 		JBrowse link
G Slc7a7 solute carrier family 7 member 7 decreases expression EXP Cephaloridine results in decreased expression of SLC7A7 mRNA CTD PMID:18500788 NCBI chr15:33,013,346...33,059,733
Ensembl chr15:33,013,504...33,051,129 		JBrowse link
G Slc8a1 solute carrier family 8 member A1 decreases expression EXP Cephaloridine results in decreased expression of SLC8A1 mRNA CTD PMID:18500788 NCBI chr 6:4,244,076...4,564,262
Ensembl chr 6:4,258,991...4,520,604 		JBrowse link
G Slpi secretory leukocyte peptidase inhibitor increases expression EXP Cephaloridine results in increased expression of SLPI mRNA CTD PMID:18500788 NCBI chr 3:160,799,979...160,802,228
Ensembl chr 3:160,799,981...160,802,433 		JBrowse link
G Smyd1 SET and MYND domain containing 1 increases expression EXP Cephaloridine results in increased expression of SMYD1 mRNA CTD PMID:18500788 NCBI chr 4:99,071,122...99,125,143
Ensembl chr 4:99,074,535...99,125,111 		JBrowse link
G Snapc2 small nuclear RNA activating complex, polypeptide 2 increases expression EXP Cephaloridine results in increased expression of SNAPC2 mRNA CTD PMID:18500788 NCBI chr12:2,537,291...2,540,774
Ensembl chr12:2,537,275...2,540,668 		JBrowse link
G Socs3 suppressor of cytokine signaling 3 decreases expression EXP Cephaloridine results in decreased expression of SOCS3 mRNA CTD PMID:18500788 NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040 		JBrowse link
G Spetex-2B Spetex-2B protein increases expression EXP Cephaloridine results in increased expression of SPETEX-2B mRNA CTD PMID:18500788 NCBI chr 8:1,932,820...1,933,017 JBrowse link
G Spetex-2D Spetex-2D protein increases expression EXP Cephaloridine results in increased expression of SPETEX-2D mRNA CTD PMID:18500788
G Sphk1 sphingosine kinase 1 increases expression EXP Cephaloridine results in increased expression of SPHK1 mRNA CTD PMID:18500788 NCBI chr10:105,498,728...105,504,401
Ensembl chr10:105,498,728...105,504,393 		JBrowse link
G Spink1 serine peptidase inhibitor, Kazal type 1 decreases expression EXP Cephaloridine results in decreased expression of SPINK1 mRNA CTD PMID:18500788 NCBI chr18:38,221,919...38,242,092
Ensembl chr18:38,221,681...38,242,119 		JBrowse link
G Srpra SRP receptor subunit alpha decreases expression EXP Cephaloridine results in decreased expression of SRPRA mRNA CTD PMID:18500788 NCBI chr 8:36,410,683...36,416,766
Ensembl chr 8:36,410,683...36,416,296 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 increases expression EXP Cephaloridine results in increased expression of STAT3 mRNA CTD PMID:18500788 NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233 		JBrowse link
G Stk35 serine/threonine kinase 35 increases expression EXP Cephaloridine results in increased expression of STK35 mRNA CTD PMID:18500788 NCBI chr 3:122,307,976...122,340,205
Ensembl chr 3:122,308,025...122,336,468 		JBrowse link
G Stra6 signaling receptor and transporter of retinol STRA6 decreases expression EXP Cephaloridine results in decreased expression of STRA6 mRNA CTD PMID:18500788 NCBI chr 8:62,925,364...62,944,438
Ensembl chr 8:62,925,357...62,944,437 		JBrowse link
G Sult1c2a sulfotransferase family, cytosolic, 1C, member 2a decreases expression EXP Cephaloridine results in decreased expression of SULT1C2 mRNA; Cephaloridine results in decreased expression of SULT1C2A mRNA CTD PMID:18500788 NCBI chr 9:4,152,588...4,168,355
Ensembl chr 9:4,152,589...4,168,221 		JBrowse link
G Sult4a1 sulfotransferase family 4A, member 1 increases expression EXP Cephaloridine results in increased expression of SULT4A1 mRNA CTD PMID:18500788 NCBI chr 7:124,958,546...124,982,602
Ensembl chr 7:124,958,546...124,982,566 		JBrowse link
G Surf6 surfeit 6 decreases expression EXP Cephaloridine results in decreased expression of SURF6 mRNA CTD PMID:18500788 NCBI chr 3:5,441,404...5,452,156
Ensembl chr 3:5,441,409...5,452,156 		JBrowse link
G Susd2 sushi domain containing 2 decreases expression EXP Cephaloridine results in decreased expression of SUSD2 mRNA CTD PMID:18500788 NCBI chr20:13,965,098...13,972,547
Ensembl chr20:13,965,121...13,972,547 		JBrowse link
G Syne1 spectrin repeat containing nuclear envelope protein 1 decreases expression EXP Cephaloridine results in decreased expression of SYNE1 mRNA CTD PMID:18500788 NCBI chr 1:41,608,287...41,763,591
NCBI chr 1:41,844,840...42,086,662
Ensembl chr 1:41,608,418...42,077,535 		JBrowse link
G Syne2 spectrin repeat containing nuclear envelope protein 2 decreases expression EXP Cephaloridine results in decreased expression of SYNE2 mRNA CTD PMID:18500788 NCBI chr 6:98,884,269...99,153,551 JBrowse link
G Sytl5 synaptotagmin-like 5 increases expression EXP Cephaloridine results in increased expression of SYTL5 mRNA CTD PMID:18500788 NCBI chr  X:13,857,669...14,109,592
Ensembl chr  X:14,019,961...14,109,568 		JBrowse link
G Tac3 tachykinin precursor 3 increases expression EXP Cephaloridine results in increased expression of TAC2 mRNA CTD PMID:18500788 NCBI chr 7:71,023,976...71,030,582
Ensembl chr 7:71,023,976...71,030,582 		JBrowse link
G Tbx3 T-box transcription factor 3 decreases expression EXP Cephaloridine results in decreased expression of TBX3 mRNA CTD PMID:18500788 NCBI chr12:42,479,518...42,494,588
Ensembl chr12:42,480,560...42,492,526 		JBrowse link
G Tcf12 transcription factor 12 decreases expression EXP Cephaloridine results in decreased expression of TCF12 mRNA CTD PMID:18500788 NCBI chr 8:78,343,634...78,657,738
Ensembl chr 8:78,345,754...78,655,856 		JBrowse link
G Tcf19 transcription factor 19 increases expression EXP Cephaloridine results in increased expression of TCF19 mRNA CTD PMID:18500788 NCBI chr20:3,740,454...3,746,964
Ensembl chr20:3,744,395...3,746,964 		JBrowse link
G Tfrc transferrin receptor increases expression EXP Cephaloridine results in increased expression of TFRC mRNA CTD PMID:18500788 NCBI chr11:71,397,423...71,419,263
Ensembl chr11:71,397,383...71,419,223 		JBrowse link
G Ticrr TOPBP1-interacting checkpoint and replication regulator increases expression EXP Cephaloridine results in increased expression of TICRR mRNA CTD PMID:18500788 NCBI chr 1:141,391,738...141,433,615
Ensembl chr 1:141,391,262...141,433,109 		JBrowse link
G Timeless timeless circadian regulator increases expression EXP Cephaloridine results in increased expression of TIMELESS mRNA CTD PMID:18500788 NCBI chr 7:2,643,288...2,667,329
Ensembl chr 7:2,643,288...2,667,628 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression EXP Cephaloridine results in increased expression of TIMP1 mRNA CTD PMID:18500788 NCBI chr  X:1,364,771...1,369,451
Ensembl chr  X:1,364,786...1,369,384 		JBrowse link
G Tlr2 toll-like receptor 2 increases expression EXP Cephaloridine results in increased expression of TLR2 mRNA CTD PMID:18500788 NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061 		JBrowse link
G Tmem163 transmembrane protein 163 increases expression EXP Cephaloridine results in increased expression of TMEM163 mRNA CTD PMID:18500788 NCBI chr13:44,166,306...44,345,735
Ensembl chr13:44,166,306...44,345,735 		JBrowse link
G Tmem252 transmembrane protein 252 decreases expression EXP Cephaloridine results in decreased expression of TMEM252 mRNA CTD PMID:18500788 NCBI chr 1:242,572,558...242,577,817
Ensembl chr 1:242,572,533...242,577,817 		JBrowse link
G Tmem270 transmembrane protein 270 increases expression EXP Cephaloridine results in increased expression of TMEM270 mRNA CTD PMID:18500788 NCBI chr12:24,803,204...24,808,287
Ensembl chr12:24,803,686...24,808,288 		JBrowse link
G Tmem63c transmembrane protein 63c increases expression EXP Cephaloridine results in increased expression of TMEM63C mRNA CTD PMID:18500788 NCBI chr 6:111,044,099...111,120,659
Ensembl chr 6:111,049,559...111,120,799 		JBrowse link
G Tmem86a transmembrane protein 86A decreases expression EXP Cephaloridine results in decreased expression of TMEM86A mRNA CTD PMID:18500788 NCBI chr 1:103,173,032...103,177,382
Ensembl chr 1:103,172,987...103,177,417 		JBrowse link
G Tnfrsf12a TNF receptor superfamily member 12A increases expression EXP Cephaloridine results in increased expression of TNFRSF12A mRNA CTD PMID:18500788 NCBI chr10:12,995,904...12,997,930
Ensembl chr10:12,995,904...12,997,930 		JBrowse link
G Tnfrsf1a TNF receptor superfamily member 1A increases expression EXP Cephaloridine results in increased expression of TNFRSF1A mRNA CTD PMID:18500788 NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633 		JBrowse link
G Tns1 tensin 1 decreases expression EXP Cephaloridine results in decreased expression of TNS1 mRNA CTD PMID:18500788 NCBI chr 9:81,190,192...81,401,020
Ensembl chr 9:81,194,119...81,400,987 		JBrowse link
G Tns4 tensin 4 increases expression EXP Cephaloridine results in increased expression of TNS4 mRNA CTD PMID:18500788 NCBI chr10:86,977,504...87,001,256
Ensembl chr10:86,977,505...87,001,256 		JBrowse link
G Tonsl tonsoku-like, DNA repair protein increases expression EXP Cephaloridine results in increased expression of TONSL mRNA CTD PMID:18500788 NCBI chr 7:117,688,397...117,703,139
Ensembl chr 7:117,688,397...117,703,094 		JBrowse link
G Top2a DNA topoisomerase II alpha decreases expression EXP Cephaloridine results in decreased expression of TOP2A mRNA CTD PMID:18500788 NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154 		JBrowse link
G Tph1 tryptophan hydroxylase 1 increases expression EXP Cephaloridine results in increased expression of TPH1 mRNA CTD PMID:18500788 NCBI chr 1:102,669,868...102,699,442
Ensembl chr 1:102,669,868...102,699,442 		JBrowse link
G Trib3 tribbles pseudokinase 3 increases expression EXP Cephaloridine results in increased expression of TRIB3 mRNA CTD PMID:18500788 NCBI chr 3:147,814,056...147,819,650
Ensembl chr 3:147,813,473...147,819,571 		JBrowse link
G Tril TLR4 interactor with leucine-rich repeats decreases expression EXP Cephaloridine results in decreased expression of TRIL mRNA CTD PMID:18500788 NCBI chr 4:83,967,695...83,972,540
Ensembl chr 4:83,967,696...83,972,540 		JBrowse link
G Trpc6 transient receptor potential cation channel, subfamily C, member 6 increases expression EXP Cephaloridine results in increased expression of TRPC6 mRNA CTD PMID:18500788 NCBI chr 8:6,811,543...6,917,534
Ensembl chr 8:6,811,543...6,917,535 		JBrowse link
G Ttc39a tetratricopeptide repeat domain 39A increases expression EXP Cephaloridine results in increased expression of TTC39A mRNA CTD PMID:18500788 NCBI chr 5:129,024,505...129,083,226
Ensembl chr 5:129,043,675...129,082,442
Ensembl chr 5:129,043,675...129,082,442 		JBrowse link
G Ttk Ttk protein kinase decreases expression EXP Cephaloridine results in decreased expression of TTK mRNA CTD PMID:18500788 NCBI chr 8:91,368,065...91,405,995
Ensembl chr 8:91,368,111...91,405,993 		JBrowse link
G Ttll2 tubulin tyrosine ligase like 2 increases expression EXP Cephaloridine results in increased expression of TTLL2 mRNA CTD PMID:18500788 NCBI chr 1:53,561,142...53,570,118
Ensembl chr 1:53,561,218...53,563,032 		JBrowse link
G Tubb3 tubulin, beta 3 class III increases expression EXP Cephaloridine results in increased expression of TUBB3 mRNA CTD PMID:18500788 NCBI chr19:56,220,759...56,229,813
Ensembl chr19:56,220,755...56,229,813 		JBrowse link
G Tubb6 tubulin, beta 6 class V increases expression EXP Cephaloridine results in increased expression of TUBB6 mRNA CTD PMID:18500788 NCBI chr18:63,130,542...63,140,181
Ensembl chr18:63,130,542...63,140,181 		JBrowse link
G Tyms thymidylate synthetase increases expression EXP Cephaloridine results in increased expression of TYMS mRNA CTD PMID:18500788 NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564 		JBrowse link
G Ubd ubiquitin D increases expression EXP Cephaloridine results in increased expression of UBD mRNA CTD PMID:18500788 NCBI chr20:1,876,175...1,878,126
Ensembl chr20:1,876,173...1,897,814 		JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C decreases expression EXP Cephaloridine results in decreased expression of UBE2C mRNA CTD PMID:18500788 NCBI chr 3:161,236,971...161,239,371
Ensembl chr 3:161,236,898...161,241,159 		JBrowse link
G Ube2l6 ubiquitin-conjugating enzyme E2L 6 increases expression EXP Cephaloridine results in increased expression of UBE2L6 mRNA CTD PMID:18500788 NCBI chr 3:72,191,533...72,206,190
Ensembl chr 3:72,191,533...72,206,188 		JBrowse link
G Ubl7 ubiquitin-like 7 increases expression EXP Cephaloridine results in increased expression of UBL7 mRNA CTD PMID:18500788 NCBI chr 8:62,696,557...62,715,694
Ensembl chr 8:62,696,720...62,714,017 		JBrowse link
G Uchl1 ubiquitin C-terminal hydrolase L1 increases expression EXP Cephaloridine results in increased expression of UCHL1 mRNA CTD PMID:18500788 NCBI chr14:43,133,224...43,143,942
Ensembl chr14:43,133,218...43,143,973 		JBrowse link
G Ugt1a2 UDP glucuronosyltransferase 1 family, polypeptide A2 increases expression EXP Cephaloridine results in increased expression of UGT1A2 mRNA CTD PMID:18500788 NCBI chr 9:95,285,592...95,302,822
Ensembl chr 9:95,161,157...95,302,822 		JBrowse link
G Ugt1a6 UDP glucuronosyltransferase family 1 member A6 increases expression EXP Cephaloridine results in increased expression of UGT1A6 mRNA CTD PMID:18500788 NCBI chr 9:95,241,609...95,302,822
Ensembl chr 9:95,161,157...95,302,822 		JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 increases expression EXP Cephaloridine results in increased expression of UGT2B7 mRNA CTD PMID:18500788 NCBI chr14:22,597,103...22,619,968 JBrowse link
G Uhmk1 U2AF homology motif kinase 1 increases expression EXP Cephaloridine results in increased expression of UHMK1 mRNA CTD PMID:18500788 NCBI chr13:88,521,625...88,536,728
Ensembl chr13:88,521,625...88,536,728 		JBrowse link
G Upp1 uridine phosphorylase 1 increases expression EXP Cephaloridine results in increased expression of UPP1 mRNA CTD PMID:18500788 NCBI chr14:89,314,234...89,334,060
Ensembl chr14:89,314,176...89,334,276 		JBrowse link
G Usp24 ubiquitin specific peptidase 24 decreases expression EXP Cephaloridine results in decreased expression of USP24 mRNA CTD PMID:18500788 NCBI chr 5:125,896,725...126,030,411
Ensembl chr 5:125,896,725...126,030,401 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 increases expression EXP Cephaloridine results in increased expression of VCAM1 mRNA CTD PMID:18500788 NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619 		JBrowse link
G Vpreb3 V-set pre-B cell surrogate light chain 3 increases expression EXP Cephaloridine results in increased expression of VPREB3 mRNA CTD PMID:18500788 NCBI chr20:13,656,683...13,661,542
Ensembl chr20:13,656,825...13,657,943 		JBrowse link
G Wdhd1 WD repeat and HMG-box DNA binding protein 1 increases expression EXP Cephaloridine results in increased expression of WDHD1 mRNA CTD PMID:18500788 NCBI chr15:24,021,674...24,056,073
Ensembl chr15:24,021,674...24,056,073 		JBrowse link
G Zc3h13 zinc finger CCCH type containing 13 decreases expression EXP Cephaloridine results in decreased expression of ZC3H13 mRNA CTD PMID:18500788 NCBI chr15:57,340,522...57,405,287
Ensembl chr15:57,340,579...57,405,287 		JBrowse link
G Zdhhc18 zinc finger DHHC-type palmitoyltransferase 18 decreases expression EXP Cephaloridine results in decreased expression of ZDHHC18 mRNA CTD PMID:18500788 NCBI chr 5:151,829,795...151,856,256
Ensembl chr 5:151,831,527...151,856,256 		JBrowse link
G Zfand2a zinc finger AN1-type containing 2A decreases expression EXP Cephaloridine results in decreased expression of ZFAND2A mRNA CTD PMID:18500788 NCBI chr12:17,252,093...17,263,477
Ensembl chr12:17,252,093...17,263,477 		JBrowse link
G Zfp367 zinc finger protein 367 increases expression EXP Cephaloridine results in increased expression of ZFP367 mRNA CTD PMID:18500788 NCBI chr17:1,652,892...1,672,021
Ensembl chr17:1,652,895...1,672,021 		JBrowse link
cefalotin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions ISO [Cephalothin co-treated with Neomycin] results in increased expression of ABCB11 mRNA CTD PMID:24657338 NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions ISO [Cephalothin co-treated with Neomycin] results in increased expression of ABCC2 mRNA CTD PMID:24657338 NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 multiple interactions ISO [Cephalothin co-treated with Neomycin] results in increased expression of ABCC3 mRNA CTD PMID:24657338 NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression ISO Cephalothin results in increased expression of BAX protein CTD PMID:15012731 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO Cephalothin results in increased cleavage of and results in increased activity of CASP3 protein CTD PMID:15012731 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204 		JBrowse link
G Cyp8b1 cytochrome P450 family 8 subfamily B member 1 multiple interactions ISO [Cephalothin co-treated with Neomycin] results in decreased expression of CYP8B1 mRNA CTD PMID:24657338 NCBI chr 8:130,548,418...130,550,388
Ensembl chr 8:130,548,418...130,550,388 		JBrowse link
G Fgf19 fibroblast growth factor 19 multiple interactions ISO [Cephalothin co-treated with Neomycin] results in increased expression of FGF15 mRNA CTD PMID:24657338 NCBI chr 1:218,058,405...218,061,693
Ensembl chr 1:218,058,405...218,061,693 		JBrowse link
G Npc1l1 NPC1 like intracellular cholesterol transporter 1 multiple interactions ISO [Cephalothin co-treated with Neomycin] results in increased expression of NPC1L1 mRNA CTD PMID:24657338 NCBI chr14:86,345,946...86,560,694
Ensembl chr14:86,345,953...86,560,694 		JBrowse link
G Nr5a2 nuclear receptor subfamily 5, group A, member 2 multiple interactions ISO [Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA CTD PMID:24657338 NCBI chr13:53,750,470...53,870,288
Ensembl chr13:53,750,473...53,870,428 		JBrowse link
G Slc10a1 solute carrier family 10 member 1 multiple interactions ISO [Cephalothin co-treated with Neomycin] results in increased expression of SLC10A1 mRNA CTD PMID:24657338 NCBI chr 6:104,617,730...104,631,355
Ensembl chr 6:104,617,730...104,631,355 		JBrowse link
G Slc25a20 solute carrier family 25 member 20 multiple interactions EXP Cephalothin binds to and results in decreased activity of SLC25A20 protein; Cephalothin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine] CTD PMID:18452908 NCBI chr 8:117,455,308...117,476,762
Ensembl chr 8:117,455,262...117,476,734 		JBrowse link
G Slc51b solute carrier family 51 subunit beta multiple interactions ISO [Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA CTD PMID:24657338 NCBI chr 8:70,930,196...70,938,559
Ensembl chr 8:70,930,347...70,932,986 		JBrowse link
G Slco1b2 solute carrier organic anion transporter family member 1B2 multiple interactions ISO [Cephalothin co-treated with Neomycin] results in increased expression of SLCO1B2 mRNA CTD PMID:24657338 NCBI chr 4:175,814,118...175,881,775
Ensembl chr 4:175,814,118...175,881,768 		JBrowse link
G Tp53 tumor protein p53 increases expression ISO Cephalothin results in increased expression of TP53 protein CTD PMID:15012731 NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449 		JBrowse link
G Vdr vitamin D receptor multiple interactions ISO [Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA CTD PMID:24657338 NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166 		JBrowse link
cefazolin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Dhfr dihydrofolate reductase decreases activity ISO Cefazolin results in decreased activity of DHFR protein CTD PMID:25418905 NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453 		JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
increases expression		 ISO Cefazolin results in increased expression of and results in decreased activity of GSR protein
Cefazolin results in increased expression of GSR mRNA		 CTD PMID:32196862 NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361 		JBrowse link
G RT1-DOa RT1 class II, locus DOa affects expression ISO Cefazolin affects the expression of HLA-DOA mRNA CTD PMID:25811541 NCBI chr20:3,889,106...3,892,360
Ensembl chr20:3,889,370...3,892,449 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 increases uptake ISO SLC22A8 protein results in increased uptake of Cefazolin CTD PMID:16098483 NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482 		JBrowse link
G Slc25a20 solute carrier family 25 member 20 multiple interactions EXP Cefazolin binds to and results in decreased activity of SLC25A20 protein; Cefazolin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine] CTD PMID:18452908 NCBI chr 8:117,455,308...117,476,762
Ensembl chr 8:117,455,262...117,476,734 		JBrowse link
cefdinir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc22a6 solute carrier family 22 member 6 multiple interactions
increases uptake		 ISO cefdinir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
SLC22A6 protein results in increased uptake of cefdinir		 CTD PMID:16098483 NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 multiple interactions
increases uptake		 ISO cefdinir inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
SLC22A8 protein results in increased uptake of cefdinir		 CTD PMID:16098483 NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482 		JBrowse link
cefepime term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Arhgap45 Rho GTPase activating protein 45 affects expression ISO cefepime affects the expression of ARHGAP45 mRNA CTD PMID:25811541 NCBI chr 7:12,541,032...12,741,314
Ensembl chr 7:12,541,061...12,741,296 		JBrowse link
G Cat catalase multiple interactions ISO cefepime inhibits the reaction [Amikacin results in decreased activity of CAT protein] CTD PMID:18781908 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058 		JBrowse link
G Dhfr dihydrofolate reductase decreases activity ISO cefepime results in decreased activity of DHFR protein CTD PMID:25418905 NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453 		JBrowse link
G Pgd phosphogluconate dehydrogenase decreases activity EXP cefepime results in decreased activity of PGD protein CTD PMID:15558954 NCBI chr 5:165,966,128...165,982,327 JBrowse link
G RT1-Db1 RT1 class II, locus Db1 affects expression ISO cefepime affects the expression of HLA-DRB1 mRNA CTD PMID:25811541 NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190 		JBrowse link
cefixime term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Rab8a RAB8A, member RAS oncogene family multiple interactions
increases uptake		 ISO [RAB8A protein results in increased localization of SLC15A1 protein] which results in increased uptake of Cefixime
RAB8A protein results in increased uptake of Cefixime		 CTD PMID:19074526 NCBI chr16:19,355,047...19,376,776
Ensembl chr16:19,355,048...19,376,776 		JBrowse link
G Slc15a1 solute carrier family 15 member 1 multiple interactions
increases uptake		 ISO [RAB8A protein results in increased localization of SLC15A1 protein] which results in increased uptake of Cefixime
SLC15A1 protein results in increased uptake of Cefixime		 CTD PMID:19074526 NCBI chr15:106,800,081...106,844,668
Ensembl chr15:106,800,081...106,844,426 		JBrowse link
cefmetazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcc4 ATP binding cassette subfamily C member 4 increases transport ISO ABCC4 protein results in increased transport of Cefmetazole CTD PMID:17939016 NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592 		JBrowse link
cefonicid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc25a20 solute carrier family 25 member 20 multiple interactions EXP Cefonicid binds to and results in decreased activity of SLC25A20 protein; Cefonicid inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine] CTD PMID:18452908 NCBI chr 8:117,455,308...117,476,762
Ensembl chr 8:117,455,262...117,476,734 		JBrowse link
cefoperazone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc22a7 solute carrier family 22 member 7 multiple interactions ISO Cefoperazone inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates] CTD PMID:12065749 NCBI chr 9:16,925,321...16,931,119
Ensembl chr 9:16,924,520...16,931,766 		JBrowse link
cefoselis sulfate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc22a6 solute carrier family 22 member 6 multiple interactions ISO cefoselis inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] CTD PMID:16098483 NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 increases uptake
multiple interactions		 ISO SLC22A8 protein results in increased uptake of cefoselis
cefoselis inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]		 CTD PMID:16098483 NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482 		JBrowse link
cefotaxime term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bax BCL2 associated X, apoptosis regulator increases expression ISO Cefotaxime results in increased expression of BAX protein CTD PMID:15012731 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207 		JBrowse link
G Il10 interleukin 10 multiple interactions ISO Cefotaxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] CTD PMID:16939481 NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392 		JBrowse link
G Pgd phosphogluconate dehydrogenase decreases activity EXP Cefotaxime results in decreased activity of PGD protein CTD PMID:15558954 NCBI chr 5:165,966,128...165,982,327 JBrowse link
G RT1-CE5 RT1 class I, locus CE5 affects expression ISO Cefotaxime affects the expression of HLA-F mRNA CTD PMID:25811541 NCBI chr20:4,892,702...4,896,993
Ensembl chr20:4,892,702...4,896,991 		JBrowse link
G Tp53 tumor protein p53 increases expression ISO Cefotaxime results in increased expression of TP53 protein CTD PMID:15012731 NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449 		JBrowse link
cefotiam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc22a6 solute carrier family 22 member 6 multiple interactions ISO Cefotiam inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] CTD PMID:16098483 NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 increases uptake
multiple interactions		 ISO SLC22A8 protein results in increased uptake of Cefotiam
Cefotiam inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]		 CTD PMID:16098483 NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482 		JBrowse link
cefoxitin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G LOC100364500 RT1 class I, locus CE11-like affects expression ISO Cefoxitin affects the expression of HLA-A mRNA CTD PMID:25811541 NCBI chr20:2,704,153...2,707,111
Ensembl chr20:2,704,148...2,707,120 		JBrowse link
G RT1-Ha RT1 class II, locus Ha affects expression ISO Cefoxitin affects the expression of HLA-DPA1 mRNA CTD PMID:25811541 NCBI chr20:3,875,478...3,885,140
Ensembl chr20:3,875,706...3,881,461 		JBrowse link
cefpodoxime term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Prl prolactin increases expression ISO cefpodoxime results in increased expression of PRL protein CTD PMID:20083845 NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299 		JBrowse link
ceftazidime pentahydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcc4 ATP binding cassette subfamily C member 4 increases transport ISO ABCC4 protein results in increased transport of Ceftazidime CTD PMID:17939016 NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592 		JBrowse link
G Dhfr dihydrofolate reductase decreases activity ISO Ceftazidime results in decreased activity of DHFR protein CTD PMID:25418905 NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453 		JBrowse link
G Il10 interleukin 10 multiple interactions ISO Ceftazidime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] CTD PMID:16939481 NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392 		JBrowse link
ceftibuten term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc15a1 solute carrier family 15 member 1 multiple interactions ISO [Zinc results in decreased activity of SLC15A1 protein] which results in decreased uptake of ceftibuten CTD PMID:14567632 NCBI chr15:106,800,081...106,844,668
Ensembl chr15:106,800,081...106,844,426 		JBrowse link
G Slc22a6 solute carrier family 22 member 6 increases uptake
multiple interactions		 ISO SLC22A6 protein results in increased uptake of ceftibuten
ceftibuten inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]		 CTD PMID:16098483 NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 increases uptake
multiple interactions		 ISO SLC22A8 protein results in increased uptake of ceftibuten
ceftibuten inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]		 CTD PMID:16098483 NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482 		JBrowse link
ceftizoxime term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Dhfr dihydrofolate reductase decreases activity ISO Ceftizoxime results in decreased activity of DHFR protein CTD PMID:25418905 NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453 		JBrowse link
G Slc22a6 solute carrier family 22 member 6 multiple interactions
increases uptake		 ISO Ceftizoxime inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
SLC22A6 protein results in increased uptake of Ceftizoxime		 CTD PMID:16098483 NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 increases uptake
multiple interactions		 ISO SLC22A8 protein results in increased uptake of Ceftizoxime
Ceftizoxime inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]		 CTD PMID:16098483 NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482 		JBrowse link
ceftriaxone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ace2 angiotensin I converting enzyme 2 decreases expression EXP Ceftriaxone results in decreased expression of ACE2 mRNA CTD PMID:29745864 NCBI chr  X:32,050,734...32,095,860
Ensembl chr  X:32,049,931...32,096,016 		JBrowse link
G Actb actin, beta increases expression EXP Ceftriaxone results in increased expression of ACTB mRNA CTD PMID:29745864 NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841 		JBrowse link
G Bace1 beta-secretase 1 decreases expression EXP Ceftriaxone results in decreased expression of BACE1 mRNA CTD PMID:29745864 NCBI chr 8:50,140,092...50,162,388
Ensembl chr 8:50,139,997...50,162,361 		JBrowse link
G Cat catalase decreases expression
multiple interactions		 ISO
EXP		 Ceftriaxone results in decreased expression of CAT protein
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]]		 CTD PMID:19442074 PMID:25053526 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058 		JBrowse link
G Dhfr dihydrofolate reductase decreases activity ISO Ceftriaxone results in decreased activity of DHFR protein CTD PMID:25418905 NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453 		JBrowse link
G Ece1 endothelin converting enzyme 1 increases expression EXP Ceftriaxone results in increased expression of ECE1 mRNA CTD PMID:29745864 NCBI chr 5:156,215,469...156,318,652
Ensembl chr 5:156,215,417...156,318,671 		JBrowse link
G Epo erythropoietin increases expression EXP Ceftriaxone results in increased expression of EPO mRNA CTD PMID:29745864 NCBI chr12:22,274,828...22,278,268
Ensembl chr12:22,274,828...22,278,266 		JBrowse link
G Ide insulin degrading enzyme increases expression EXP Ceftriaxone results in increased expression of IDE mRNA CTD PMID:29745864 NCBI chr 1:255,914,465...256,014,168
Ensembl chr 1:255,914,447...256,013,495 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]] CTD PMID:25053526 NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726 		JBrowse link
G Mme membrane metallo-endopeptidase increases expression EXP Ceftriaxone results in increased expression of MME mRNA CTD PMID:29745864 NCBI chr 2:153,799,203...153,880,910
Ensembl chr 2:153,803,349...153,880,738 		JBrowse link
G Slc1a2 solute carrier family 1 member 2 multiple interactions
increases expression		 EXP Ceftriaxone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein]; Ceftriaxone promotes the reaction [Kainic Acid results in increased expression of SLC1A2 protein]
Ceftriaxone results in increased expression of SLC1A2 protein		 CTD PMID:19625514 PMID:19717140 PMID:28257918 PMID:29045497 NCBI chr 3:92,518,679...92,665,731
Ensembl chr 3:92,640,752...92,665,644 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 multiple interactions EXP Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein] CTD PMID:19717140 NCBI chr 2:139,453,774...139,528,479
Ensembl chr 2:139,453,774...139,528,162 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]] CTD PMID:25053526 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 		JBrowse link
cefuroxime term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cat catalase decreases activity EXP Cefuroxime results in decreased activity of CAT protein CTD PMID:30797828 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058 		JBrowse link
G Il10 interleukin 10 multiple interactions ISO Cefuroxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] CTD PMID:16939481 NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392 		JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 decreases activity ISO Cefuroxime results in decreased activity of NFE2L2 protein CTD PMID:30203046 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 decreases activity ISO Cefuroxime results in decreased activity of NR1I3 protein CTD PMID:30203046 NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha decreases activity ISO Cefuroxime results in decreased activity of PPARA protein CTD PMID:30203046 NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752 		JBrowse link
G RT1-Bb RT1 class II, locus Bb affects expression ISO Cefuroxime affects the expression of HLA-DQB1 mRNA CTD PMID:25811541 NCBI chr20:4,043,726...4,049,367
Ensembl chr20:4,039,413...4,049,711 		JBrowse link
G RT1-S3 RT1 class Ib, locus S3 affects expression ISO Cefuroxime affects the expression of HLA-E mRNA CTD PMID:25811541 NCBI chr20:3,176,124...3,180,825
Ensembl chr20:3,176,107...3,179,818 		JBrowse link
cephalexin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G RT1-Ha RT1 class II, locus Ha affects expression ISO Cephalexin affects the expression of HLA-DPA1 mRNA CTD PMID:25811541 NCBI chr20:3,875,478...3,885,140
Ensembl chr20:3,875,706...3,881,461 		JBrowse link
G Slc15a1 solute carrier family 15 member 1 increases transport EXP SLC15A1 protein results in increased transport of Cephalexin CTD PMID:19881305 NCBI chr15:106,800,081...106,844,668
Ensembl chr15:106,800,081...106,844,426 		JBrowse link
cephalosporin C term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcc4 ATP binding cassette subfamily C member 4 increases transport ISO ABCC4 protein results in increased transport of cephalosporin C CTD PMID:17939016 NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592 		JBrowse link
cephradine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc15a1 solute carrier family 15 member 1 multiple interactions ISO [Zinc results in decreased activity of SLC15A1 protein] which results in decreased uptake of Cephradine CTD PMID:14567632 NCBI chr15:106,800,081...106,844,668
Ensembl chr15:106,800,081...106,844,426 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19841
    role 19792
      application 19465
        pharmaceutical 19338
          drug 19338
            drug allergen 9926
              cephalosporin 545
                (6R)-7-[(2-amino-1-oxo-2-phenylethyl)amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7R)-3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 0
                (6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-8-oxo-3-[(2H-triazol-4-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid propane-1,2-diol 0
                (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-(2-carboxypropan-2-yloxyimino)-1-oxoethyl]amino]-8-oxo-3-(1-pyridin-1-iumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-(carboxymethoxyimino)-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-[oxo(propan-2-yloxy)methoxy]ethyl ester 0
                (6R,7R)-7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7S)-3-(acetyloxymethyl)-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7S)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[[(2R)-1-oxo-2-phenyl-2-sulfoethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7S)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7S)-7-[[2-(2-amino-4-thiazolyl)-1-oxoethyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-5-tetrazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (6R,7S)-7-[[2-[2-(aminomethyl)phenyl]-1-oxoethyl]amino]-3-[[[1-(carboxymethyl)-5-tetrazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                (7R)-7-(4-carboxybutanamido)cephalosporanic acid 0
                (7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanic acid 0
                (7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                3-(acetyloxymethyl)-7-[[3-(4-chloro-3,5-dimethyl-1-pyrazolyl)-2-methyl-1-oxopropyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                3-(carbamoyloxymethyl)cephalosporin + 7
                3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                3-hydroxymethylcephalosporin + 0
                4-\{((R)-2-Carboxy-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-en-7-ylcarbamoyl)-[(Z)-methoxyimino]-methyl\}-thiazol-2-yl-ammonium + 0
                7-[[2-(4-chloro-3,5-dimethyl-1-pyrazolyl)-1-oxoethyl]amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                7-[[2-(4-chloro-3-methyl-1-pyrazolyl)-1-oxopropyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                7-[[2-[5-cyclopropyl-3-(difluoromethyl)-1-pyrazolyl]-1-oxoethyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-8-oxo-3-prop-1-enyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                7beta-aminodeacetoxycephalosporanic acid 0
                Cefazolin sodium hydrate 0
                Cefodizime sodium 0
                Ceftriaxone disodium salt hemiheptahydrate 0
                Cefuroxime axetil 0
                LSM-5500 0
                LSM-5644 0
                LSM-5686 0
                O-formylcefamandole 0
                cefacetrile 0
                cefaclor 4
                cefadroxil + 1
                cefaloglycin 0
                cefaloridine 493
                cefalotin + 15
                cefamandole + 0
                cefathiamidine 0
                cefatrizine 0
                cefazedone 0
                cefazolin 5
                cefbuperazone 0
                cefcapene 0
                cefclidin 0
                cefdaloxime 0
                cefdinir 2
                cefditoren + 0
                cefepime 5
                cefepime hydrochloride 0
                cefepime(1+) + 0
                cefetamet 0
                cefiderocol 0
                cefixime 2
                cefluprenam 0
                cefmenoxime + 0
                cefmetazole 1
                cefodizime 0
                cefonicid 1
                cefoperazone 1
                ceforanide 0
                cefoselis + 2
                cefotaxime 5
                cefotiam + 2
                cefoxitin 2
                cefozopran 0
                cefpiramide 0
                cefpirome + 0
                cefpodoxime + 1
                cefpodoxime proxetil 0
                cefprozil 0
                cefroxadine 0
                cefsulodin 0
                ceftaroline + 0
                ceftaroline fosamil + 0
                ceftazidime + 3
                cefteram 0
                ceftezole 0
                ceftibuten + 3
                ceftiolene 0
                ceftizoxime 3
                ceftobiprole 0
                ceftobiprole medocaril 0
                ceftolozane 0
                ceftriaxone 13
                cefuroxime pivoxetil 0
                cefuzonam 0
                cephalexin + 2
                cephalosporanic acid + 14
                cephalosporin C + 1
                cephapirin 0
                cephapirin sodium 0
                cephradine 1
                deacetoxycephalosporin C 0
                moxalactam 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19841
    subatomic particle 19839
      composite particle 19839
        hadron 19839
          baryon 19839
            nucleon 19839
              atomic nucleus 19839
                atom 19839
                  main group element atom 19732
                    p-block element atom 19732
                      carbon group element atom 19636
                        carbon atom 19625
                          organic molecular entity 19625
                            organic group 18537
                              organic divalent group 18528
                                organodiyl group 18528
                                  carbonyl group 18436
                                    carbonyl compound 18436
                                      carboxylic acid 18113
                                        carboacyl group 17377
                                          univalent carboacyl group 17377
                                            carbamoyl group 17164
                                              carboxamide 17164
                                                lactam 8034
                                                  beta-lactam 793
                                                    beta-lactam antibiotic 781
                                                      cephem 546
                                                        cephalosporin 545
                                                          (6R)-7-[(2-amino-1-oxo-2-phenylethyl)amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7R)-3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 0
                                                          (6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-8-oxo-3-[(2H-triazol-4-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid propane-1,2-diol 0
                                                          (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-(2-carboxypropan-2-yloxyimino)-1-oxoethyl]amino]-8-oxo-3-(1-pyridin-1-iumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-(carboxymethoxyimino)-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-[oxo(propan-2-yloxy)methoxy]ethyl ester 0
                                                          (6R,7R)-7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7S)-3-(acetyloxymethyl)-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7S)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[[(2R)-1-oxo-2-phenyl-2-sulfoethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7S)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7S)-7-[[2-(2-amino-4-thiazolyl)-1-oxoethyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-5-tetrazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (6R,7S)-7-[[2-[2-(aminomethyl)phenyl]-1-oxoethyl]amino]-3-[[[1-(carboxymethyl)-5-tetrazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          (7R)-7-(4-carboxybutanamido)cephalosporanic acid 0
                                                          (7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanic acid 0
                                                          (7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          3-(acetyloxymethyl)-7-[[3-(4-chloro-3,5-dimethyl-1-pyrazolyl)-2-methyl-1-oxopropyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          3-(carbamoyloxymethyl)cephalosporin + 7
                                                          3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          3-hydroxymethylcephalosporin + 0
                                                          4-\{((R)-2-Carboxy-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-en-7-ylcarbamoyl)-[(Z)-methoxyimino]-methyl\}-thiazol-2-yl-ammonium + 0
                                                          7-[[2-(4-chloro-3,5-dimethyl-1-pyrazolyl)-1-oxoethyl]amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          7-[[2-(4-chloro-3-methyl-1-pyrazolyl)-1-oxopropyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          7-[[2-[5-cyclopropyl-3-(difluoromethyl)-1-pyrazolyl]-1-oxoethyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-8-oxo-3-prop-1-enyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                                          7beta-aminodeacetoxycephalosporanic acid 0
                                                          Cefazolin sodium hydrate 0
                                                          Cefodizime sodium 0
                                                          Ceftriaxone disodium salt hemiheptahydrate 0
                                                          Cefuroxime axetil 0
                                                          LSM-5500 0
                                                          LSM-5644 0
                                                          LSM-5686 0
                                                          O-formylcefamandole 0
                                                          cefacetrile 0
                                                          cefaclor 4
                                                          cefadroxil + 1
                                                          cefaloglycin 0
                                                          cefaloridine 493
                                                          cefalotin + 15
                                                          cefamandole + 0
                                                          cefathiamidine 0
                                                          cefatrizine 0
                                                          cefazedone 0
                                                          cefazolin 5
                                                          cefbuperazone 0
                                                          cefcapene 0
                                                          cefclidin 0
                                                          cefdaloxime 0
                                                          cefdinir 2
                                                          cefditoren + 0
                                                          cefepime 5
                                                          cefepime hydrochloride 0
                                                          cefepime(1+) + 0
                                                          cefetamet 0
                                                          cefiderocol 0
                                                          cefixime 2
                                                          cefluprenam 0
                                                          cefmenoxime + 0
                                                          cefmetazole 1
                                                          cefodizime 0
                                                          cefonicid 1
                                                          cefoperazone 1
                                                          ceforanide 0
                                                          cefoselis + 2
                                                          cefotaxime 5
                                                          cefotiam + 2
                                                          cefoxitin 2
                                                          cefozopran 0
                                                          cefpiramide 0
                                                          cefpirome + 0
                                                          cefpodoxime + 1
                                                          cefpodoxime proxetil 0
                                                          cefprozil 0
                                                          cefroxadine 0
                                                          cefsulodin 0
                                                          ceftaroline + 0
                                                          ceftaroline fosamil + 0
                                                          ceftazidime + 3
                                                          cefteram 0
                                                          ceftezole 0
                                                          ceftibuten + 3
                                                          ceftiolene 0
                                                          ceftizoxime 3
                                                          ceftobiprole 0
                                                          ceftobiprole medocaril 0
                                                          ceftolozane 0
                                                          ceftriaxone 13
                                                          cefuroxime pivoxetil 0
                                                          cefuzonam 0
                                                          cephalexin + 2
                                                          cephalosporanic acid + 14
                                                          cephalosporin C + 1
                                                          cephapirin 0
                                                          cephapirin sodium 0
                                                          cephradine 1
                                                          deacetoxycephalosporin C 0
                                                          moxalactam 0
paths to the root